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Electrically-responsive biomaterials such as conductive polymers and conductive 
hydrogels have piqued the interest of scientists for targeted payload delivery 
applications in recent years since generating electricity is easy. Conductive composite 
hydrogels are a specific class of hydrogel that can be designed to not only have 
mechanical properties similar to skin and soft tissue, but can also have electrical 
properties comparable to metals and organic semiconductors. These composite 
hydrogels have been considered for a wide range of technological applications. 
Conductive hydrogels can be fabricated to ensure that they exhibit: 1) excellent 
biocompatibility; 2) soft and tunable mechanical properties similar to biological tissue; 
3) mixed electronic/ionic conductivity that promotes efficient signal transduction for 
delivering drugs to the tissue; 4) ability to create materials with well-controlled 
microstructure; and 5) ability to be loaded with wide range of molecular size 
molecules with different molecular charge; thereby making conductive hydrogels a 
stronger tool for targeted delivery applications.  
This dissertation focuses on describing a novel method of creating hydrogel 
composites from the commercially available conductive polymer PEDOT (poly(3,4-
ethylenedioxythiophene):polystyrene sulfonate). The resulting method allows for fast 
production of conductive hydrogels, and does not need specific equipment. In this 
method of production, a wide range of mechanical properties can be achieved by 
altering hydrogel composition and production temperature without jeopardizing the 
electrical properties of the hydrogels by using conductive polymer. Additionally, this 
 
 
method could be employed for fabrication of conductive composite hydrogels with a 
variety of polymers and cross-linkers. 
Chapter two provides an overview on electrically-responsive targeted delivery 
depots with respect to their release mechanisms from electrical stimulation, parameters 
affecting drug release with electricity, and current efforts on multi-drug delivery using 
electrically-responsive materials. 
In chapter three, we explored the production and application of pAAc-PEDOT 
(poly acrylic acid-poly(3,4-ethylenedioxthiophene):polystyrene sulfonate) cryogels. 
Our goal was to develop soft, injectable, and conducting hydrogel-based electrode 
materials, and to characterize their sustained mechanical and electrical properties 
before and after sterilization and injection. Biocompatibility, cytotoxicity, and drug 
delivery capability of these cryogels were also investigated. pAAc-PEDOT cryogels 
were made at a subfreezing temperature to generate a macroporous structure within 
the gels. The resulting porous hydrogels exhibited enhanced mechanical properties. 
The cryogels exhibited softness (0.2-20 kPa), excellent toughness, and strain of 
failure, and could survive injection through 16-gauge needle. Additionally, these gels 
demonstrated the capability of recording alpha oscillations. Last but not least, these 
cryogels were found to be biocompatible and were capable of being loaded with and 
delivering proteins.  
In chapter four, we investigated the integration of conductive hydrogels (alginate-
PEDOT) with tripolar concentric ring electrodes (TCREs). Our goal was to develop 
hydrogel-integrated electrodes with isolated channels to improve the quality of 
recorded signals. To this end, we fabricated alginate-PEDOT hydrogels and explored 
 
 
their mechanical and electrical properties to identify an optimized hydrogel 
formulation. We also investigated the channel isolation of our proposed electrode 
design. Furthermore, we used our novel electrode to record neural activity and 
compared recorded signals of hydrogel TCREs with those of conductive paste.   
Chapter five provides overall conclusions for this dissertation as well as 
comments on potential future work. 
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closed. (C) EEG recording from occipital lobe using TEN20 paste (red) compared to 
hydrogel 2.5 mm lead electrode (blue), while subject eyes were opened. Alfa wave 
was disappeared as soon as eyes opened. (D) Power spectrum from occipital lobe 
using TEN20 paste (red) compared to hydrogel 2.5 mm lead electrode (blue) while 
subject eyes were open. Alfa wave was gone as soon as eyes were opened. For all 
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Figure 4.9. TCRHE had higher power spectrum comparing to TCRE with Ten20 paste 
over time. 8 - 13 Hz (alpha wave) while subject’s eyes were closed. N = 4 for all parts. 
* indicates p-values < 0.05, ** indicates p-values < 0.01, *** indicates p-values < 
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(a) Compressive modulus vs. acrylic acid concentration for gels crosslinked with 1 
wt% (red), 2 wt% (blue), and 5 wt% (green) PEGDM. “No gelation” indicates that 
there was not enough polymer and crosslinker to form a 3D gel structure and therefore 
no measurement could be taken. (b) Table summarizing statistically significant 
differences of moduli between different hydrogel formulations. N = 4 ................... 131 
 
Figure A2. The electrical properties of these hydrogels are not significantly impacted 
by acrylic acid and PEGDM crosslinking concentration. (a) I-V curves for gels 
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wt% AAc. (b) Computed DC electrical conductivity for various 0.26 wt% PEDOT 
hydrogel formulations when excited using (i) 0.5 V, (ii) 2 V, (iii) 4 V, and (iv) 8 V. 
n.s. indicates no statistically significant differences. N = 4. Note that some gel 
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the dashed line at 90% indicates that compression tests never exceeded 90% as to not 
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Figure A4. Nanoporous PEDOT/pAAc gel formulations swelled well beyond their 
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PEDOT/pAAc gels vs. acrylic acid concentration for gels crosslinked with 1 wt% 
(red), 2 wt% (blue), and 5 wt% (green) PEGDM. “No gelation” indicates that there 
was not enough polymer and crosslinker to form a 3D gel structure and therefore no 
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Figure A8. Exposure to PEDOT cryogels did not visually impact the skin. Subject 
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(green). n.s. indicates that no statistically significant differences were observed (N = 
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High impedance between channels indicates isolation.  (A) Isolation between middle 
ring to center disc. Red for TCRE with Ten20 paste, blue for 2.5 mm TCR hydrogel 
electrode (2.5 mm TCRHE) and green 5 mm TCR hydrogel electrode (5 mm TCRHE) 
(2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT).  (B) Isolation between center 
disc to outer ring. Red for TCRE with Ten20 paste, blue for 2.5 mm TCR hydrogel 
electrode (2.5 mm TCRHE) and green 5 mm TCR hydrogel electrode (5 mm TCRHE) 
(2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT). (C) Isolation between outer 
ring to middle ring. Red for TCRE with Ten20 paste, blue for 2.5 mm TCR hydrogel 
electrode (2.5 mm TCRHE) and green 5 mm TCR hydrogel electrode (5 mm TCRHE) 
(2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT). N = 4 for all parts .......... 142 
 
Figure B2. TCR hydrogel electrode have higher amplitude and significantly improves 
power spectrum comparing to TCRE with Ten20 paste. (A) EEG recording from 
occipital lobe using TEN20 paste (red) compared to hydrogel (2.5 mm lead electrode 
(blue) and 5 mm lead electrode) while subject eyes were closed. (i) Inset: zoom-in 
EEG recording while eyes were closed. (B) Power spectrum from occipital lobe using 
TEN20 paste (red) compared to hydrogel (2.5 mm electrode lead (blue) and 5 mm lead 
electrode (green)) while subject eyes were closed. (i) Inset: zoom-in power spectra, 
highlighting the recording of alpha waves (8-13 Hz) while eyes were closed. (C) EEG 
recording from occipital lobe using TEN20 paste (red) compared to hydrogel (2.5 mm 
lead electrode (blue) and 5 mm lead electrode) while subject eyes were opened. Alfa 
wave was gone as soon as eyes were opened. (D) Power spectrum from occipital lobe 
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1. Introduction and Motivation 
Neuroprosthetic devices have been developed in order to return function, or to 
reduce symptoms exhibited by patients suffering from neurological diseases [1]. For 
instance, electrical therapies such as cochlear implants [2, 3] and deep brain 
stimulation [4, 5] are promising strategies in treating patients with neurological 
diseases. While promising, these strategies are not without limitations [1]. For 
example, the strategies require sustained tissue-electrode interface over time [6] and 
the electrodes must minimize overpotential at the tissue-electrode interface, and 
maintain a conductive path between the electrode and the tissue being stimulated. 
Traditionally, metallic electrodes have been used for stimulation of neural tissue. 
Despite their outstanding electrical properties over short periods of time, metallic 
electrodes do not maintain these properties over long periods of time [7]. In addition, 
introduction of these electrodes to patients requires invasive surgery that often 
ruptures neurons and blood vessels and activates a foreign body response at the site of 
electrode tissue interface [1]. Additionally, the mismatch between the mechanical 
properties of the electrode and tissue can cause shear stress at the interface, which can 
in turn result in prolonged inflammation at the site of electrode, and eventually the loss 
of connection between the electrode and surrounding tissue [8-11]. These constraints 
pose limitations for the application of the commonly-used electrodes over extended 




Electroencephalography (EEG) is an affordable, non-invasive technique used to 
measure electrical impulses generated by brain activity. The EEG has excellent 
temporal resolution, which is ideal for diagnosing neurological diseases. For example, 
EEG is currently used for diagnosing diseases such as epilepsy and head trauma [12, 
13]. Furthermore, it is extensively used in neuro-rehabilitation applications such as in 
the brain-computer interface to help control the movement of prosthetic limbs in 
patients with paralysis. [14-17]. However, while EEG has an excellent temporal 
resolution, it has a limited spatial resolution. Because of the aforementioned benefits 
offered by EEG, several methods, such as surface Laplacian, have been designed to 
improve the spatial resolution of EEG. Surface Laplacian methods not only enhance 
spatial selectivity, but also attenuate universal noise and improve signal-to-noise ratio 
[16, 18-23]. Several electrodes have been designed based on surface Laplacian theory, 
which have a center disc and one or more rings around the center disc [18, 24]. These 
electrodes are often made of metals, which require electrical connections with the 
scalp. To successfully make a connection between electrodes and a patient’s skin, 
conductive paste is typically used [25]. While conductive paste significantly improves 
the electrode-skin interface, it also partially electrically shorts the channels of 
electrodes and affects the quality of recorded signals. Moreover, conductive paste 
dries out over time, negatively affecting the quality of signal and increasing noise over 
time. These obstacles limit the application of conductive paste where EEG 
spatiotemporal resolution over time is vital. Given the constraints of EEG-based 
neuroprosthetic devices with respect to their current methods and the limitations of 




effective electrical connection between the scalp and electrode, be formed into a 
desired shape for the given application, and retain its integrity for long periods of time. 
To address the aforementioned issues, we first aimed to develop an improved 
conductive interface between tissue and the electrode using conductive hydrogels. 
Hydrogels are soft materials made from cross-linked hydrophilic polymeric networks 
[26]. Although hydrogels themselves are insoluble in water, they can preserve a large 
fraction of water within their network for prolonged periods of time while successfully 
retaining their 3D structure [27]. Conductive polymer hydrogels are a unique class of 
hydrogels, which not only have similar mechanical properties to tissue [28], but also 
have similar electrical properties to metals and inorganic semiconductors [29]. There 
are currently several conductive polymers available, which have been widely used for 
fabricating conductive hydrogels [30]. It has been demonstrated that the conductive 
polymer poly(3-4, ethylenedioxythiophene) (PEDOT) provides better conductivity and 
stability in oxidized environments than other widely used conductive polymers [31-
36]. Moreover, PEDOT is biocompatible [37]. Thus, for the purpose of this study, 
PEDOT was used as the conductive component of the electrically conductive 
hydrogel. 
PEDOT is a conjugated polymer with an outstanding chemical stability [30, 38] 
owing to the fact that the EDOT monomer has only two reactive hydrogens, which 
means that it is unlikely to have chemical defects in the PEDOT chain [39]. PEDOT is 
commonly used in its oxidative state where some of electrons are removed from main 
chain, generating positive carriers, and thus makes the polymer electrically conductive 




suspension by doping it with different types of anions such as poly(styrene sulfonate) 
(PSS) [39]. PEDOT and its water soluble PEDOT:PSS are the most commonly used 
conducting polymers [38]. 
For the resulting injectable conductive hydrogel systems, we employed a shape 
memory technique during hydrogel synthesis by fabricating the hydrogels at a 
subfreezing temperature, which results in hydrogels with interconnected macropores 
[41]. The ability of the hydrogels to maintain their shape can allow for minimally 
invasive implantation of the gels at the application site [42]. The novel method of 
conductive hydrogel fabrication used in the described studies utilized a commercially 
available conductive polymer, which allows for fast production without the need for 
special equipment. In addition, the resulting synthesis methods could be possibly used 
to fabricate conductive hydrogels with variety of polymer types for a wide variety of 
applications. 
While PEDOT hydrogels have been created previously, they have yet to be 
employed as a means to enhance the spatial resolution of multi-channel electrode 
systems by providing soft, 3D conducting structures that retain their shape and 
moisture over prolonged periods of time. Thus, the work proposed here is a novel step 
forward in the context of contemporary technologies related to neuroprosthetics.  
Overall, we hypothesized that by integrating the conductive polymer PEDOT 
within a hydrogel network and designing the morphology of the resulting conductive 
hydrogels based on the given application, that a sustained conductive interface 
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Electrically-Responsive Targeted Delivery Depots  
 
2.1 Introduction 
Electrical stimulation can be used for a variety of treatments such as pain 
management [1-4], neuromuscular dysfunction [5], strength training [6], improving 
local blood flow [7], motor control and retardation of muscle atrophy [2, 8, 9], 
improving joint mobility [10], tissue repair [9] and wound healing [11-13], and acute 
and chronic edema [14-17]. Electrical stimulation has also been used for drug delivery 
[18], brain computer interface (BCI) [5], deep brain stimulation [19], cochlear 
implants [20, 21], transcranial direct current stimulation (tDCS) [7], etc.  
Stimuli-responsive biomaterials have garnered great interest in recent years for 
their use in drug delivery applications [25]. Although many delivery systems have 
been developed that can respond to electromagnetic fields, light, ultrasound, or pH 
[23-25], activating these systems requires the use of large and specialized devices. On 
the other hand, generating electric stimuli typically does not require large or 
specialized equipment [26, 27]. Moreover, designing and miniaturizing the type of 
equipment required for applying electrical stimulation is an advantage [28] of using 
electrical stimulation for drug delivery applications. Hydrogels serve as drug 
reservoirs where drugs can be physically entrapped within hydrogel network [29, 30], 
have electrostatic interactions with hydrogel network [31-33], or bind with conductive 




Electrically stimulated drug delivery systems are platforms that allow localized 
and on-demand drug release for a variety of applications [39]. For example, electrical 
pulses can enhance membrane permeability in drug delivery systems [40-42], and can 
allow for the delivery of large molecules such as peptides, proteins, nucleotides [43, 
44], and therapeutic agents such as insulin and chemotherapeutics, which often face 
difficulties in being released from biomaterials [27, 45]. Electrical stimulation of 
membranes loaded with these therapeutics could enhance effective drug delivery by 
enhancing membrane permeability [46]. The application of electroporation 
(electropermeability) has been used to develop a new cancer treatment modality, 
known as electrochemotherapy, over the past two decades [45]. Moreover, drug 
delivery systems have been employed for the delivery of therapeutics for treatment of 
diseases such as Alzheimer's disease [39] and epilepsy [47], which require the delivery 
of agents able to overcome the low permeability of blood-brain barrier.  
Locally delivering therapeutics to tissues has been a challenge for a long time. 
One of the methods used to address this is the design of drug-loaded microchips and 
their implantation in the vicinity of the tissue needing access to the therapeutics. 
Microchips provide excellent local and on-demand release of single or multiple drugs 
and they can deliver a multitude of therapeutic forms, including liquids, solids, and 
gels [48-50]. The downside of using microchips is that they require invasive surgery 
for implantation, and implanting microchips for a prolonged time could cause 
inflammation at the implantation site. Moreover, microchips have a low-capacity 
reservoir (<1 μL) [51]. When higher dosage of drug needs to be delivered, it requires a 




issues, conductive hydrogels [34, 52], conductive polymers [39, 53, 54], and 
conductive sol-gels [14] have been developed as electrically-responsive drug delivery 
depots.     
For drug delivery with electrical stimulation, direct current (DC) stimulation is 
commonly used to apply an electric field [55]; however, DC stimulation can be a 
potential physical and electrical hazard to the skin and tissue at the site of the 
electrode-tissue interface. Temperature, acid/base, or other types of chemical burns 
may cause skin irritation, burns, and in extreme cases when tissue is exposed to an 
electric field for a prolonged period of time, causes tissue necrosis [56]. As a result, 
local temperature, pH, and electrode overpotential needs to be monitored to avoid 
tissue irritation and local burns. In addition, using a safe electric current density and 
duration and conductive paste can minimize the side effects of electrical stimulation 
[37, 55, 56].  
While exposing tissue to electric fields for prolonged periods can increase the 
risk of burn and tissue necrosis due to local changes in temperature and pH [55], 
controlled local increases of temperature via electrical stimulation, known as 
radiofrequency ablation, has been used [57]. In this method, electrodes are inserted 
inside tissue in order to induce controlled tissue necrosis for the treatment of a variety 
of diseases, including cancer [57, 58]. Moreover, radiofrequency ablation can be 
combined with chemotherapy, allowing for chemotherapeutic agents to be released in 






2.2. Release mechanisms from electrical stimulation 
 
2.2.1 Drug release by pressure 
When a DC electric field has been applied to hydrogels between electrodes, it 
induces anisotropic deformation and ion shift in the hydrogels [60], which causes 
mobile ions to move toward the counter-electrode, causing local pH and osmotic 
pressure changes. As a result, the hydrogels shrink when pressure is increased and 
swell when pressure is decreased [60-64], and consequently, the pressure on the anode 
side is not the same as the pressure on the cathode side [65-68]. Additionally, free ions 
in the surrounding solution move toward the counter-electrode and move into the 
hydrogel network [69, 70] (Figure 2.1). A uniaxial stress gradient, caused by 
electrostatic forces, plays an important role in the deformation of hydrogels [61, 65, 
71], and these deformations are reversible so that once an electric field is removed the 
hydrogel regains its original shape [29, 69, 72]. A change in pH within a hydrogel can 
result in a volume change (swelling [37, 47], shrinkage/deswelling [29, 56, 66, 73]), or 
deformation (bending) [42, 69, 74, 75]) depending on the hydrogel charge and 
surrounding electric field strength. As a result, a pH change in the hydrogel at the site 
of a working electrode could result in drug release [31].  
Both pH changes and deformation can contribute to the release of drugs from 
hydrogels. For neutral drugs, one primary mechanism is involved in drug release - the 
deformation of the hydrogel matrix at the working electrode [66]. However, for 
charged drugs, three mechanisms are involved in drug release: ion exchange, 




cathode or vice versa depending on the electric field direction [67]. Figure 2.2 
demonstrates the effect of electric field application on drug release. When the electric 
field is off, there is no matrix deformation, volume change, or drug release (Figure 
2.2A). As soon as an electric field is applied the matrix shrinks (Figure 2.2B) or swells 
(Figure 2.2C) depending on the hydrogel properties, allowing for effective release of 
































Figure 2. Matrices deform and drug releases once an electric field is applied.  
Representative hydrogel microstructure with (A) no electric field, (B) electric field 
applied with matrix shrinkage, (C) electric field applied with matrix swelling. 
 
2.2.2 Drug release by matrix degradation 
Electrical stimulation of hydrogels can result in the migration of ions towards 
the counter-electrode, which can result in localized changes in pH. As a result, a 
change in pH can cause matrix degradation and drug release [76-80]. Moreover, the 
rate of drug release depends on pH, where the drug release rate is higher at lower pH 
and decreases when the pH increases [76]. Figure 2.3 illustrates the degradation of a 
hydrogel matrix when an electric field is applied, and Figure 2.4 demonstrates how 













Figure 2.3. Schematic of hydrogel degradation and drug release upon applying 
an electric field. (A) no electric field is applied and no drug release occurs, and (B) 

























Figure 2.4 Surface erosion of a matrix can occur upon applying an electric field. 
Graphs show weight loss of poly(ethyloxazolion)-poly-(methacrylic acid) complexed 
in 0.9% saline when 10 mA current is passed with a (A) continuous current or (B) 










2.3. Parameters affecting drug release via electricity 
For electrically-controlled drug release from biomaterials, sol-gels [81, 82], 
hydrogels [66, 76], and conductive polymers [35, 83] have been used as drug 
reservoirs. For typical drug delivery systems, hydrogels are more common than 
conductive polymers, since conductive polymers have certain limitations and are only 
needed in certain applications. For example, only charged drugs with certain sizes can 
be released from biomaterials using electrical stimulation [52, 84]. Hydrogels offer 
many advantages in drug delivery applications including their tunable mechanical 
properties, biocompatibility, biodegradability, and high water content [28, 62, 68]. 
Additionally, the three-dimensional structure of hydrogels allows for the 
immobilization of large molecules such as protein, peptides, and DNA-based drugs 
[85, 86]. Unfortunately, hydrogels on their own typically exhibit poor electrical 
behavior [87]. One type of hydrogel that can be used to overcome this limitation is 
electrolyte hydrogels, which can be used for controlled released [37, 64, 66]. In 
addition, materials can be incorporated into hydrogel to improve their conductivity. 
These materials include conductive polymers [30, 35], conductive polymer 
nanoparticles [78, 81], carbon nanotubes [56, 88], dielectric nanoparticles [30], 
graphene [89] and metal nanoparticles such as silver [90]. In addition to enhancing 
conductivity these materials can also reduce diffusion of drug from hydrogel [37], and 
thus this limitation needs to be taken into consideration when designing electrically-
conductive hydrogel systems for drug delivery applications. 
 




Adequate characterization of the molecular interaction of matrices with drugs 
is critical for developing an effective and reliable electrically-stimulation drug 
delivery system. One of the most import factors that needs to be taken into 
consideration in the design of matrix formulations is drug charge [32, 66, 70]. 
Although the delivery of ionic drugs is common with electrical stimulation, non-ionic 
drugs also can be loaded to matrixes for this application, but often at lower 
concentrations than ionic drugs. The molecular interactions between charged drug and 
charged matrix can increase the loading capacity of hydrogels [70]. In addition, drug 
release rates decrease with increasing drug size [32] and Figure 2.5 demonstrates that 
larger drug sizes results in lower drug release rates. 
 
Figure 2.5 Drug release rate decreases with increasing drug size. Tannic acid has 
the largest size and therefore has the lowest release rate. Benzoic acid has the smallest 
size and hence has the highest release rate. Benzoic acid Mw = 122. Folic acid Mw = 




2.3.2 Effect of matrix concentration and cross-linking 
Increasing matrix concentration and charge will enhance its response to 
electric fields [64, 91], thereby impacting the release of drugs from the systems. 
Another factor that can affect the release rates of drugs from matrixes is the cross-
linking ratio of the hydrogel systems. Increasing the cross-linking ratio decreases the 
porosity of hydrogel resulting in a decrease in the drug release rate [34, 92-05]], as 
shown in Figure 2.6. Increasing the cross-linking ratio also decreases molecular 
mobility with in the hydrogel matrix [96]. Polymer molecular weight affects the cross-
linking ratio of hydrogel systems, where shorter molecular weight chains result in 
larger free volumes and chain ends within the hydrogels [75]. In addition, increasing 





Figure 2.6. Increasing the cross-linking ratio in hydrogels decreases the rate of 
drug release. Amount of folic acid released from alginate-calcium (Alg-Ca) hydrogels 
with 0.3, 0.7, and 1.3 cross-linking ratios [32]. 
 
2.3.3 Effect of adding conductive materials  
Hydrogels that are responsive to electrical stimulation are sometimes known as 
electrolyte hydrogels [64]. In general, the addition of conductive agents to electrolyte 
hydrogels will enhance their conductivity [34, 56, 62, 80, 82, 91] and after electrical 
stimulation, increase drug release [34, 62]. Samples with higher conductivity can 
deform more significantly, which can result in enhanced drug release [56, 73, 98]. 
Despite these advantages, there is a limit for increasing the amount of conductive 
additives to hydrogels, as increasing too much can result in sedimentation of the 
conductive agent [56, 73, 99], or not significantly improve the conductivity of the 
hydrogel system [62]. Moreover, high loading of a conductive agent can result in 
increased cross-linking between the polymer chain added agent, thereby restraining 
chain movement so that the hydrogel exhibits a smaller mesh size, less swelling, and 
hence a minimized drug release rate [34, 68, 100]. If a large amount of conductive 
nanoparticles are loaded into a hydrogel, they have the potential to allow for a burst of 
drug out of the hydrogel and/or result in local damage to the matrix due to stress of 
removing the electric field (due to matrix deformation while electric field is applied). 
For multi-pulsatile release profiles, it is imperative to choose a conductive agent-
polymer ratio which prevents diffusion [62] and allows for the constant release of drug 




effect of adding conductive agent to hydrogel on drug release rates and Figure 2.8 
shows the effect of adding graphene and carbon nanotubes to hydrogels on mechanical 
and electrical properties. 
A B
 
Figure 2.7. Increasing the amount of conductive agent enhances the drug release 
rate. (A) Pulsatile drug release from a hydrogel upon applying electric field. Drug 
release was monitored while applying an electric field for 5 minutes every 60 minutes. 
The pulsatile release of C-sucrose was determined for blank hydrogels and hydrogels 
with 0.05 mg/ml, 0.1 mg/mls and 0.2 mg/ml of pMWNT (pristine multi-wall carbon 
nanotubes). (B) C-sucrose release rates from the described hydrogels. Rates of release 








Figure 2.8. Adding conductive agents to hydrogels enhance their mechanical 
properties and improves their electrical properties. (A) Stress-strain curve for an 
acrylic acid hydrogel with and without graphene. Increasing the amount of graphene 
particles in the hydrogel increases hydrogel stiffness and toughness [65]. (B)  
Electrical properties of poly(methacrylic) acid hydrogel improves with the addition of 
carbon nanotubes, where increasing carbon nanotube concentration decreases 
resistance [59]. 
 
2.3.4 Effect of electric field polarity 
Electric field polarity is one the most important factors in the controlled release 
of drugs from electrically-responsive materials. Electric fields generate a driving force 
that enhances drug release by generating electro-repulsive forces between the drug and 
electrode with the same charge, which increases the rate of drug release [28, 32, 34, 
84, 88]. Pairatwachapun et al. showed that the release rate of a positively charged drug 
is the highest when a cathode (negatively charged electrode) is placed on the hydrogel 




al. [84] demonstrated that the drug release rate of a negatively charged drug is highest 
under a cathode. Figure 2.9 shows the release of a negatively charged drug under a 
cathode and anode. The negatively charged electrode generated electro-repulsion 
forces towards the negatively charge drug, and consequently had a higher release rate.  
 
Figure 2.9. Drug release in response to electrical stimulation of opposite polarity. 
Release of benzoic acid from a benzoic acid-loaded poly(vinyl acid) hydrogel in 





2.3.5 Effect of electric field strength 
Electric field strength has a significant impact on drug release from 
electrically-responsive hydrogels, where increasing voltage can result in an increase in 
the drug release rate [32, 33, 51, 56, 92, 94, 99, 102]. The deformation of conductive 
hydrogel matrices depends on the electric field intensity and hydrogel charge. With 
increasing voltage, deformation increases [42, 69, 74]. Increasing electric field 
strength can increase the shrinkage at the anode site and swelling at the cathode site, 
which both result in increased drug release rate [33, 67, 94]. Figure 2.10 demonstrates 
the effect of increasing electric field strength on drug release rate, where increasing 
voltage resulted in an increase in the drug release rate. 
 
Figure 2.10. Drug release rate increases with increasing electric field strength. 
Drug release from poly(AA-co-AMPS)/carrageenan/RGO (poly(acrylic acid-co-2-
acrylamido-2-methyl-1-propanesulfonic acid)/carrageenan/reduced graphene oxide) 
hydrogels with  different electric field strengths. Samples was placed between parallel 




 2.3.6 Effect of duration of an applied electric field 
Increasing the exposure time of matrixes to electric fields can enhance drug 
release [29, 35, 92]. At the same time, increasing the duration of an applied electric 
field can result in an increase in temperature, especially for a hydrogel network with 
high impedance [56]. Any increase in temperature above 41-42 °C during electrical 
stimulation can induce tissue necrosis and should be avoided [89]. Seravant et al. 
showed that by adjusting strength and duration of an applied electric field, the 
temperature increase could be controlled to minimize its effect on the environment 
surrounding the implanted hydrogel. Fortunately, drug release from electrically-
stimulated hydrogel matrices can be fast. For example, drug release can be 
successfully achieved upon applying an electric field of 1 V for 10 seconds [78]. 
Carbon nanotubes exhibit excellent thermal conductivity and exposing a carbon 
nanotube-loaded hydrogel to a DC electric field (10 V for 2 minutes) resulted in an 
increase in temperature up to 15 °C in the bulk hydrogel [89].  
 
2.3.7 Effect of pH 
Solution pH affects the release rate of drugs from hydrogels, where negatively 
charged drugs exhibit a higher release rate at higher pH (pH = 8) than neutral or 
positive states (pH = 5) due to electro-repulsion forces [88]. For systems that are pH-
sensitive, drug release solely depends on an applied electric field at neutral pH [99]. 
As mentioned earlier, electrical stimulation can result in pH changes in a hydrogel 
system, where the pH change occurs locally around electrode and not in the bulk of 




in pH above 13 can result in tissue necrosis [37]. To avoid tissue damage, electric field 
strength and application time should be monitored closely, where with increasing 
applied voltage, exposure time should be decreased [37]. 
 
2.3.8 Effect of direction of electric field 
Strain in hydrogels following deformation is due to the pressure and therefore 
this effect is isotropic. As a result, drug release from hydrogel does not depend on the 
direction of an applied electric field and it can be applied from any direction [106]. 
 
2.3.9 Effect of porosity and mesh size 
Larger pore sizes in hydrogels enhance drug and ion mobility in and 
throughout the hydrogel matrix [64, 79, 107], and as a result the quantity of drug 
released is higher from hydrogels with larger pore sizes. Larger pore sizes can be 
obtained within hydrogels by using a smaller crosslinking ratio [33, 34, 84, 92]. Figure 
2.11 demonstrates the correlation of drug diffusion from a hydrogel with the hydrogel 
mesh size and cross-linking ratio, where drug diffusion is enhanced by increasing the 










Figure 2.11. Diffusion increases with increasing mesh size and decreases 
with increasing cross-linking. Diffusion coefficient of benzoic acid from poly(vinyl 
alcohol) hydrogels in relation to mesh size and cross-linking ratio without presence of 
electric field [33]. 
 
2.3.10 Effect of diffusion 
Depending on drug and hydrogel/polymer interactions, passive diffusion of the 
drug from the hydrogel matrix can occur [62, 84]. In order to eliminate passive 
diffusion of drugs from hydrogel networks and to improve on-demand drug delivery, 
dopants have been added to a wide variety of hydrogel systems. Conductive polymer 




drug release and improve on-demand drug release from drug depots [31, 78, 81].  
Figure 2.12. demonstrates that by encapsulating a drug into conductive nanoparticles, 
passive diffusion (cumulative release) of the drug from matrix can be prevented. Drug 
release rate from dopants depends on the molecule size and exposure time [31]. 
Increasing dopant concentration will increase release rate up to a point, and increasing 
it beyond a certain concentration will no longer enhance release [61]. 
 
Figure 2.12. Cumulative release (c.r.) from hydrogel can be prevented by 
encapsulating drug with nanoparticles. Cumulative release is observed from 
hydrogel with nanoparticles of polypyrrole [81]. 
 
2.3.11 Effect of applying electric field on tissue permeability 
Electrical stimulation of tissue can increase the permeability of skin. Figure 
2.13 shows a schematic of how cell permeability is altered by applying an electric 




generated in the cellular membrane, allowing for the penetration of drugs through the 
membrane [46], which provides a unique opportunity to introduce large therapeutic 
molecules into tissue [40, 109]. Skin acts like an ion exchange membrane when it 
comes to the diffusion of drugs through the skin, where negatively charged molecules 
diffuse more slowly than positively or neutrally charged molecules. Overall, skin 
permeability will increase with increasing surface negative charge [34, 108]. Figure 
2.14 demonstrates the effect of increasing electric field strength on drug permeation, 
whereas the electric field strength increases, drug permeation increases. Additionally, 
increasing the amount of conductive agent present in a drug delivery vehicle can 
increase skin permeability [108]. Figure 2.15 shows the effect of increasing the 
amount of conductive agent in a hydrogel system on the penetration of a drug through 
the skin, where by increasing the charge of a lipogel, skin penetration increases.  
Electrotherapy also can be used to neutralize or destroy the active sites of 
growth factor enzymes. This application is important in that the concentration of 
growth factors is exponentially higher in cancerous cells in comparison to healthy 
tissue. In addition, low density DC electrotherapy can halt cell proliferation [110]. For 
example, electrical stimulation of skin can destruct the stratum corneum, and the cell 
structure becomes loose, thereby increasing cell infiltration in the dermis and 
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Figure 2.13. Electrical stimulation increases porosity of the cellular membrane by 
generating pores. (A) Drug cannot diffuse into cell due to drug size (no electrical 
stimulation). (B) Pores form in cell membrane and drug enters following electric 







Figure 2.14. Increasing electric field strength can enhance drug permeation 




Figure 2.15. With increasing surface charge skin permeation increases. In vitro 
skin permeation profiles showing ascorbyl palmitate by cathodal transport. ● neutral 
hydrogel, ○ 10% DCP (dicetylphosphate) negative lipogel, ▼20% DCP 
(dicetylphosphate) negative lipogel [108]. 
 
2.3.12 Biocompatibility  
Biocompatibility is an essential requirement for biomaterials used for 
controlled drug delivery applications [86]. High cell viability and proliferation can 




hydrogels have the potential to be biocompatible since cell viability and proliferation 
on the hydrogels is high and that all samples maintained their normal cellular 
metabolism. Histology testing on tissue surrounding hydrogels with and without 
applying an electric field has demonstrated that hydrogels can be biocompatible [56, 
68, 80]. For example, Figure 2.17 shows the potential for hydrogels to be 
biocompatible upon implantation. Since pH changes were only observed in the 
vicinity of electrodes and not in the surrounding tissue, these changes do not 
significantly affect cell growth [37]. Additionally, hydrogels can provide a substrate 
for cell adhesion and growth [82, 103, 104] making them physiologically reliable 








Figure 2.16. Conductive hydrogels are biocompatible, and cells maintain normal 
cell metabolism in direct contact with conductive hydrogels. (A) Cell proliferation 
of L929 cells exposed to conductive hydrogels and TCP (mean for n = 4  standard 
deviation). (B) Live/dead staining of L929 cells at successive culture periods for 
CP/OD1, CP/OD3, CP/OD5, C/OD and TCP, respectively. C/OD (chitosan/oxidized 
dextran), CP/OD1 (chitosan-graft-polyaniline/1 wt % oxidized dextran), CP/OD3 
(chitosan-graft-polyaniline/3 wt % oxidized dextran), CP/OD5 (chitosan-graft-
polyaniline/5 wt % oxidized dextran) and TCP (tissue culture plate) [28]. 
 
 
Figure 2.17. Conductive hydrogels are biocompatible. Figure (A) and (B) show the 
formation of a conductive hydrogel with 1 wt % polypyrrole nanoparticles after 






week and (B) two weeks post implantation. Figures C and D demonstrate hematoxylin 
and eosin (H&E)-stained images of tissues exposed to conductive hydrogels after 
subcutaneous injection into FVB mice (C) one week and (D) two weeks after 
implantation. H&E-stained cells can be seen in the hydrogel areas [81]. 
 
2.3.13 Distance of electrode from depot 
Drug release from drug reservoirs has been studied under a variety of 
conditions and generally electrodes are either in direct contact with the reservoir or 
electrodes [73]. In transdermal drug delivery and iontophoresis drug delivery, when an 
electrode is in direct contact with the skin and electrode, drugs were able to permeate 
through skin [34, 37, 62]. This method is one of the most common methods of drug 
delivery with electrical stimulation. Increasing the thickness of the drug reservoir can 
decrease permeation of the drug, likely due to the length of diffusion path [64, 94]. 
This issue can be resolved by increasing electric field strength which increases both 
drug permeation and diffusion rates. 
Most of these delivery systems require implantation of drug reservoir prior to 
stimulation. In subcutaneous drug delivery, the reservoir is implanted under the skin 
where the electrode and matrix are not in direct contact with one another, and the 
electrode is in direct contact with skin during stimulation. As discussed earlier, this 
direct contact might cause inflammation and tissue necrosis at the site of electrode 
[56]. By carefully selecting the electric field intensity, duration and polarity this issue 





Drug delivery to deep tissue is always challenging. One of the methods that 
has been developed to overcome this challenge is the integration of MEMS (Micro-
Electro-Mechanical Systems) with electro-responsive hydrogels, and fabrication of 
these implantable delivery devices for prolonged controlled drug release [29, 50]. In 
recent years, there has been a significant amount of effort to deliver drugs to areas 
which are not easily accessible, such as the central nervous systems, which has low 
access due to limited permeability across the blood brain barrier [39]. The olfactory 
region is the only site in the human body that has direct contact to the central nervous 
system. Recently, delivering drug to the brain via the olfactory region has been 
proposed, where drugs would diffuse through olfactory mucosa and reach the central 





Figure 2.18. In vivo on-demand drug release from conductive hydrogels. In vivo 
fluorescent images after applying -1.5 V/cm to the implanted conductive hydrogel on 
the left side. The right side hydrogel is the control as no electric voltage was applied to 
it. The unit of scale of the right side of the mouse image is photons per steradian per 
second. (1) Before applying electric field and (2) & (3) after applying voltage for 40 
seconds [81]. 
 
2.4. Current efforts on multi-drug delivery using electrically responsive materials 
Nanoparticles are promising depots for on-demand multi-drug delivery via 
electrical stimulation. By encapsulating drugs with different charges within 
nanoparticles on-demand release can be achieved by applying an electric field [81]. 
Luo et al. [113] developed a system consisting of polypyrrole nanoparticles within 
polypyrrole film. It incorporated a drug into the polymer as a dopant and integrated 
another drug into the nanoholes inside the polymer films. Figure 2.19 demonstrates 
on-demand multi drug-release from conductive hydrogel by controlling electric field 
polarity. In addition, microchips can be easily programmed for multi-drug release 







Figure 2.19. On-demand pulsatile multi-drug release from conductive hydrogel. 
(A) Release of fluorescein in PBS following application of -0.5 V and -1.5 V for 10 
second every 5 minutes. (B) Release of daunorubicin in PBS following application of 
0.5 V for 10 second every 5 minutes [81]. 
 
Figure 2.20. On-demand multi-drug release from a single microchip device. The 
release rate of calcium ions (∆) sodium fluorescein (●). (Release rate unit is ng/min) 
[48].  
 
2.5 Conclusions and future perspectives 
Electrically-responsive biomaterials for targeted drug delivery have gained the 




enhance membrane permeability, which can enhance absorption of drug. Moreover, 
this application is beneficial for delivering large molecules to tissue that normally 
exhibit poor absorption. The aforementioned biomaterials are biocompatible and have 
similar mechanical properties with surrounding tissue, which can minimize the foreign 
body response. By carefully selecting the hydrogel material and its properties, gels can 
be designed that incorporate drug(s) within their network. Additionally, by controlling 
morphology of these systems (mesh size and porosity), adding conductive materials, 
and controlling the electric field intensity and polarity, a desired quantity of drug 
released can be achieved without damaging the surrounding environment. 
Additionally, recent studies demonstrate that hydrogel systems can be engineered in a 
manner where multiple drugs can be delivered to the tissue.   
Wireless technologies have the potential to overcome invasiveness and the risk 
of necrosis while enabling on-demand multi-drug delivery. Conductive hydrogels are a 
promising technology that have great potential for drug delivery to deep tissue, which 
currently poses a great challenge to scientists. Hydrogel matrices can be engineered to 
release drugs using a weak electric field density where the electrophysiological 
activity of body could generate the required electric field. In addition, devices such as 
a pacemaker or pulse generator can be designed and implanted to generate the required 
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Electrically conductive materials with soft, tough, and tunable mechanics have 
utility in a wide range of applications including neuroprosthetics. Such materials can 
serve as interfaces between electrical components and tissues, providing mechanical 
matches with, and better conformations to, soft irregularly shaped surfaces. Hydrogels 
can potentially provide these attributes while remaining hydrated for long periods of 
time—providing a long-term and stable electronic-tissue interface. Additionally, in 
applications that demand implantation, hydrogels can be formulated to locally deliver 
enhancing therapeutics. Here, hydrogels are developed by entrapping a conducting 
polymer within a crosslinked poly(acrylic acid) (pAAc) network. Critically, these 
hydrogels were cast under freezing conditions which produces cryogels that exhibit 
macroporous, soft, and highly tunable mechanics (0.2 – 20 kPa, by varying pAAc and 
crosslinker concentrations). Additionally, these cryogels are tough enough to survive 
over 90% compression, which enables survival after being passed through 16-gauge 
needles. Cryogels also exhibit electrical conductivities that were sufficient to record 
alpha-waves from the scalp of human subjects. Growth of fibroblasts cultures in the 
presence of these cryogels produce statistically similar viabilities compared to controls 
and did not disrupt fibroblast cell cycles. Finally, cryogels are capable of being loaded 
with and delivering proteins that can combat inflammation. 
 







Electrically conductive materials that exhibit soft, deformable, but tough 
mechanical properties are highly desirable in a wide range of applications. For 
example, such materials could enhance neurological disorder treatment strategies—a 
family of disorders that affect up to a billion people worldwide and are on the rise due 
to gradual increases in life expectancies [1]. Neuroprosthetic devices that can restore 
functionality or reduce the symptoms exhibited by patients suffering from 
neurological diseases often require the use of electrodes to stimulate and/or record 
signals from neural tissues [2]. For instance, deep brain stimulation (DBS) uses 
implanted electrodes to electrically stimulate targets within the brain [3, 4], which can 
reduce symptoms exhibited by patients with Parkinson’s disease, essential tremor, 
dystonia, chronic pain, major depression, and obsessive-compulsive disorder [5]. Such 
strategies require an electrode-tissue interface whose electrical conductivity remains 
sufficiently high to transmit neural signals over time [6]. Metallic electrodes are 
typically used as the electrode material in these neuroprosthetic applications due to 
their high electrical conductivity. However, the stiffness of metallic electrodes can be 
problematic, especially in applications that require prolonged electrode-tissue interface 
and/or applications that demand electrode implantation within tissues. Specifically, 
stiff electrodes can have difficulty remaining in contact with soft, curvilinear surfaces 
(e.g., against the skin in electroencephalography (EEG) and electrocardiography 
(ECG) applications). Conductive pastes (such as Ten20 Conductive EEG Paste) are 




electrodes and soft surface tissues. However, they involve messy and time-consuming 
electrode preparation before use, dry up during use, and are therefore not well-suited 
for applications requiring recording/stimulating over prolonged periods of time (e.g., 
for wearable sensors and electronics). For applications that demand in vivo electrode 
implantation (e.g., DBS), maintenance of an electrically conductive path across the 
electrode-tissue interface is further complicated by the body’s ability to build fibrous 
tissue around the implanted electrode, which can greatly reduce interfacial 
conductivity [2, 7-9]. Fibrous tissue development at the electrode-tissue interface is 
thought to be the result of several factors. First, surgical introduction of a stiff metal 
electrode to sensitive tissues can be traumatic and can incite a strong inflammatory 
response. As time progresses, the mechanical mismatch between the stiff metallic 
electrode and soft tissue can lead to micromotion, shear stresses, continued 
inflammation, and a stronger foreign body reaction [2, 8]. These responses can lead to 
accelerated fibrous capsule formation around the electrode, thereby accelerating the 
loss of the requisite electrically conductive path. Because of the issues outlined above, 
this work aimed to develop a versatile material for interfacing between electronics and 
tissues that exhibited (i) soft mechanics to help facilitate conformation to curvilinear 
surfaces and to provide better mechanical matches with native tissues, (ii) sufficient 
electrical conductivity to record low-powered neural signals, (iii) tunable mechanics to 
enable application-specific customizations, (iv) toughness and compressibility to 
enable less traumatic introduction to tissues via injection, (v) low cytotoxicity, and (vi) 
the ability to locally deliver therapeutics that could potentially aid in combatting 




In order to achieve the above-listed properties, a hydrogel-based material was 
pursued. Hydrogels are soft materials made from cross-linked hydrophilic polymer 
networks [10] and have the potential to locally deliver therapeutic agents such as anti-
inflammatories [11]. Hydrogels can also have similar mechanical properties as 
physiological tissues [12]. However, they normally exhibit poor electrical conductivity 
[13] making them inappropriate for use as neuroprosthetic-tissue interface materials 
[14-16]. Electrically conductive polymer hydrogels are a unique class of hydrogels 
that not only can have similar mechanical properties as neural tissue [17, 18] but can 
also have electrical properties similar to metals and inorganic semiconductors.[19] It 
has previously been demonstrated that hydrogels composed of poly(3-4, 
ethylenedioxythiophene) (PEDOT) provide electrical conductivity and stability in 
oxidized environments [13, 20-24]. Moreover, PEDOT hydrogels in particular are 
biocompatible [25] and can have similar Young’s moduli as neural tissues [2]. For 
these reasons, PEDOT was employed as the conductive component of the hydrogel-





3.2 Experimental Section  
 
3.2.1 PEDOT/pAAc hydrogel and cryogel preparation:  
Different amounts of acrylic acid (AAc), 550 Da Poly (ethylene glycol) 
Dimethacrylate (PEGDM), sodium hydroxide (NaOH) (465 µg per ml of AAc), 
deionized water, and Poly(3,4-ethylenedioxythiophene):polystyrene sulfonate 
(PEDOT:PSS) were mixed via vortexing. Then N,N,N',N'-
Tetramethylethylenediamine (TEMED) and Ammonium Persulfate (APS) redox 
reagents were mixed in to initiate gelation and the solution was immediately 
transferred to a 10 x 10 mm cylindrical Teflon mold. This produced non-macroporous 
PEDOT/pAAc hydrogels. To produce macroporous cryogels, the same procedure was 
followed except pre-gel solutions were transferred to frozen Teflon molds (pre-frozen 
at -20 ̊C) and left to gel in a -20 ̊C freezer overnight. Both hydrogels and cryogels 
were rinsed in Phosphate Buffered Saline (PBS) for 3 days (exchanging liquid 3 times 
daily) prior to running experiments to remove excess reagents and to allow the gels to 
fully swell.  
 
3.2.2 Mechanical characterizations:  
Gel stiffness (compressive modulus), strain at failure, and toughness were 
quantitatively measured in compression using an Instron Model 3345 (Norwood, MA). 
Gels of various compositions were placed between the plates of the Instron and 
compressed (at 2 mm/min) until failure or reaching 90% strain. Note that 90% 




should the plates touch during compression. Recorded stress-strain curves were 
analyzed using the Instron’s Bluehill software package to extract moduli, strain at 
failures, and toughnesses.  
 
3.2.3 Electrical characterizations:  
For measuring IV-curves and direct current (DC) conductivity, gels of various 
composition were placed between two stainless-steel plates immediately after swelling 
in a hydrated state and excited at 0.5, 1, 2, 4, and 8 VDC. DC current was recorded 
and used to generate IV-curves. Additionally, DC conductivity was calculated at 
various voltage excitations using these measured currents along with the measured 
length and cross-sectional surface area of each fully swollen gel. For measuring 
impedance vs. frequency, all gels were cut into 12 mm diameter and 2 mm height 
discs after fully swelling. Cut gels of various composition were measured using a GW 
Instek LCR-6000 meter (New Taipei, Taiwan) at 2 VAC with 2 VDC bias from 10 Hz 
to 100 kHz.  
 
3.2.4 EEG studies:  
9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogels were cast in the 10-
mm EEG disc electrodes and rinsed/swollen as described above. These PEDOT 
electrodes were compared to electrodes integrated with Ten20 paste (Weaver and 
Company, Aurora, CO). After cleaning recording locations on the scalp with a mildly 
abrasive gel (Nuprep, Weave and Company), PEDOT-, cryoPEDOT, and Ten20-




occipital lobe and held in place with a sweat band. All recordings were in accordance 
with the University of Rhode Island IRB approved protocol. Reference and ground 
electrodes were placed on subjects’ foreheads. Each subject had one PEDOT-, one 
cryoPEDOT, and one Ten20-integrated electrode in order to record and compare the 
same neural signals. Electrodes remained on subjects for 4 hours. EEG signals were 
recorded after this 4-hour period with subject eyes being closed and opened using an 
EEG amplifier (Grass Comet-Plus EEG/PSG Amplifier system, Grass EEG systems, 
Natus Medical Incorporated) and a computer with EEG software (Grass Technologies 
EEG Twin 4.5.2).  
 
3.2.5 Gel treatment and injection:  
Only 9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM gels were used in these 
studies. Ethanol-treatment of gels involved submerging fully swollen gels in a 70% 
ethanol solution for 1 h. In a biosafety cabinet, ethanol-soaked gels were transferred to 
sterilized PBS (sterilized using a 0.22-micron vacuum filter) and rinsed for 3 days in 
sterile PBS to remove excess ethanol and to allow the gels to fully reswell (ethanol 
treatment did cause some degree of gel collapse). Autoclave-sterilization involved 
placing fully swollen gels in 250 mL media bottles containing PBS and loosely 
screwing on the media bottle lids. Gel-containing media bottles were treated in a 
Tuttanauer 2540 series autoclave (Breda, Netherlands) for 30 minutes at 121°C. After 
sterilization, the electrical and mechanical properties of these gels were characterized 




testing methods described above. For injectability, fully swollen gels were cut into 3 x 
1.25 mm cylinders and passes through 16-gauge needle with PBS. 
 
3.2.6 Fibroblast culturing:  
3T3 mouse fibroblasts were cultured in DMEM with 10% bovine calf serum 
and 1% penicillin streptomycin in 75 cm2 flasks at 37°C with 5% CO2. 3T3s were 
routinely passaged to maintain confluency under 70% by treating with 0.25% Trypsin-
EDTA for 10 min, aspirating, centrifugal washing, and re-plating in flaks with fresh 
growth media.  
 
3.2.7 Fibroblast studies:  
3T3 mouse fibroblasts were cultured and plated on 24-well plates at 1000 cells 
per cm and allowed to grow for 24 hours before being exposed to cryogels. 9 wt % 
AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogels (10 x 10 mm cylinders) were 
prepared, rinsed/swollen, ethanol-disinfected (as described above except cryogels 
were rinsed in sterilized complete DMEM on the 3rd day of post-ethanol rinsing in lieu 
of sterile PBS), and placed directly on top of 2D fibroblast cultures. After 1, 3, and 7 
days of cryogel exposure, cryogels were removed and the 3T3s were analyzed by 
LIVE/DEAD staining and imaging on a BioTek Cytation 3 plate reader (Winooski, 
VT). These images were used to calculate cell viability and live cell count vs. time 
using BioTek Gen5 software. 
 




fibroblasts were exposed to PEDOT cryogels as described above, but for 10 full 
days rather than 7 (representing 5 to 6 doubling times). After cryogel exposure 
fibroblasts were trypsinized, collected, fixed for 15 minutes in ice-cold ethanol, spun 
down (400 g for 8 minutes), resuspended in a propidium iodide (PI) staining solution 
(Nexcelom Biosciences), and incubated for 40 minutes at 37ºC. Fibroblasts were again 
spun down, resuspended in fresh PBS, loaded in to a Nexcelom Cellometer counting 
chamber, and analyzed on a Nexcelom Cellometer Vision. The Cellometer Vision 
produced PI intensity histograms and enabled the extraction of the percent of cells in 
various phases of their cycle, based on relative PI fluorescence intensity, which is 
proportional to the relative amount of DNA a cell currently has (which indicates what 
stage the cell is in its cell cycle).  
 
3.2.9 Protein release studies:  
9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogels (10 x 10 mm 
cylinders) were prepared and rinsed/swollen as described above. Cryogels were gently 
blotted using a Kimwipe to slightly dehydrate them. This slight dehydration allowed 
for IL-4 to be loaded by adding a concentrated solution of IL-4 (1000 ng and 5000 ng 
IL-4 in 100 μL PBS) dropwise to the gel. IL-4-loaded cryogels were left overnight in a 
sealed scintillation vial to allow IL-4 to integrate well into the cryogels. These 
scintillation vials were previously treated with Sigmacote to prevent binding of 
released protein to the walls of the scintillation vial. Cryogels were then submerged in 




mL samples were taken and replaced with fresh 5 mL of PBS with 1% BSA. These 
samples were analyzed for IL-4 content using ELISA (R & D Systems).   
 
3.2.10 Sample preparation for SEM imaging:  
9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogels (10 x 10 mm 
cylinders) were prepared as described in the Experimental section but lyophilized for 3 
days instead of being thawed and rinsed. After lyophilization, dehydrated cryogels 
were cut in half using a sharp razor to expose the vertical cross-section of the gel. The 
cross-cut cryogel was sputter-coated with gold for 30 seconds, mounted, and placed in 
the imaging chamber of a Zeiss SIGMA VP Field Emissions Scanning Electron 
Microscope (FE-SEM).     
 
3.2.11 Data representation and statistical analyses: All quantitative data presented in 
this work are represented as means ± standard deviations. For statistical comparisons 
that were limited to single comparisons, a student t-test was applied to calculate 
significance with p-values of less than 0.05 being our benchmark for significance. For 
instances where multiple comparisons were made across multiple conditions, one-way 
Analysis of Variance (ANOVA) with a Tukey’s post hoc test was utilized. The 
following convention was used for indicating the level of significance: *, **, ***, and 
**** indicate p < 0.05, 0.01, 0.001, and 0.0001 respectively.  “n.s.” indicates that this 





3.3 Results and Discussion 
PEDOT hydrogels were generated by entrapping PEDOT polymer within 
poly(acrylic acid) (pAAc) matrices using 550 Da poly(ethylene glycol) dimethacrylate 
(PEGDM) as a crosslinker (see Experimental Section for more details). A wide variety 
of hydrogel formations were created in order to demonstrate tunable mechanics. 
However, for each gel formulation it was desired to achieve a high and consistent 
electrical conductivity so that mechanical tuning did not overly impact electrical 
performance. Therefore, the highest amount of PEDOT was used that could be 
integrated into all gel formulations (0.26 wt% PEDOT). Indeed, by altering AAc 
monomer and PEGDM crosslinker concentrations (AAc from 4 to 10 wt% and 
PEGDM from 1 to 5 wt%), gel stiffness could be tuned over a range of moduli 
consistent with tissues (Figure A1). While different gel formulations yielded gels with 
different stiffnesses, the DC electrical properties of the gels were similar between gel 
formulations when subjected to voltages between 0.5 and 8 V (Figure A2). This 
indicates that the amount of acrylic acid and PEGDM crosslinker can be used to 
formulate gels with specific levels of stiffness without overly impacting gel electrical 
performance. Also, of note was that these gels were relatively tough and compressible, 
exhibiting particularly high strain of failures for soft, nanoporous gels (with some 
formulations surviving up to 88% compression before failing (Figure A3).  
While potentially useful in many applications including neuroprosthetic, these 
nanoporous PEDOT/pAAc gels may still present several practical limitations for use 
in applications that demand implantation. For example, their introduction to tissues 




inconvenient, and could inflame the tissue (with downstream effects limiting electrical 
conductivity). An alternative approach would be to inject the gel precursor solution 
into the tissue and cast the gel in vivo. While the APS/TEMED chemistry used for 
gelation here could be inappropriate for this, other more biologically friendly gelation 
strategies could be employed. However, even then, an issue with casting a gel within 
or against neural tissues is that the gel will swell beyond its original size after injection 
(and many of these gel formulations indeed swell greatly beyond their original casting 
size, Figure A4). While the degrees of in vitro swelling observed here would likely not 
be as severe in vivo (where there is much less water available to facilitate swelling), 
even small degrees of swelling could be painful and potentially life-threatening in or 
against sensitive neural tissues. An alternative strategy would be to first cast the gels 
ex vivo, rinse residual gelation reagents from them, allow them to fully swell, cut them 
to desired shapes/sizes, and then inject them into the tissue of interest. An electrical 
lead would be introduced to the injected gel (through the void established by the 
injection needle) and the injected gel would serve as soft interfacial buffer between the 
hard lead and the soft tissue. This injection-based approach would require a 
conducting hydrogel with highly compressible mechanics. While the PEDOT gels 
presented here exhibited mechanical properties that would suggest a high degree of 
compressibility and potential injectability, they were not capable of surviving the 
strains associated with injection. For example, after swelling fully, a gel formulation 
that exhibited a combination of being soft with high conductivity and high strain of 




compression (Figure A5a) and did not survive after being passed through a 16-guage 
needle (Figure A5b).  
In order to generate conductive hydrogel structures that were capable of surviving 
the stresses associated with injection after fully swelling, gels were engineered to have 
shape-memory properties [26] which can enable minimally invasive injection of 
hydrogel materials [27]. Shape-memory properties were achieved by adopting a 
cryogelation approach during fabrication [28] where a gel precursor solution was 
prepared (Figure 3.1a, i) and frozen during polymerization and crosslinking. Ice 
crystal nucleation and growth during freezing forced all gel constituents to the 
interstitial space between ice crystals, concentrating the matrix between ice crystals 
(Figure 3.1a, ii). After cryogelation, the mixture was thawed, leaving macropores in 
the spaces previously occupied by ice crystals (Figure 3.1a, iii). The result of this 
process was a three-dimensional structure entrapping PEDOT with a spongy, 
macroporous structure (Figure 3.1b). Just as with their room-temperature-cast 
counterparts, these PEDOT cryogels were capable of exhibiting a wide range of 
stiffness depending on their formulation (Figure 3.1c, i) with high strain of failures 
and toughness for soft hydrogels (Figure 3.1c, ii and iii). In fact, several gel 
formulations did not fail under 90% compression (Fig. 3.1c, ii and iii: denoted with ‡). 
Thus, their actual strain of failure and toughness values could not be measured since 
compressions beyond 90% were not attempted (in order to prevent equipment 
damage). Accordingly, many of the values presented here represent minimum strain of 
failure and toughness values. Elsewhere, similar cryogelation approaches have been 




biological tissues [30, 31], sufficient mechanical toughness to remain intact when 
exposed to cyclic compression (50% compression, 1000 cycles) [32], and the ability to 
spring back to form after compression through needles [28]. The novelty here is that 






Figure 3.1. Cryogelation of PEDOT/pAAc hydrogels result in macroporous 
structures with soft, tunable, and compressible mechanics. (a) Schematic detailing 
the cryogelation process. (b) Photograph (top) and SEM cross-section (bottom) of a 9 
wt% AAc, 1 wt% PEGDM, 0.26 wt% PEDOT cryogel. (c) Compressive Young’s 
modulus (i), strain of failure (ii), and toughness (iii) vs. acrylic acid concentration for 




wt% PEGDM. *, **, and **** indicate statistically significant differences with p-
values of less than 0.05, 0.01, and 0.0001, respectively (N = 4). ‡ indicates that gels 
did not fail when compressed at 90% strain. Thus, strain of failure was at least 90% 
and hydrogel toughnesses were underestimates. 
 
In order to explore the use of these hydrogels specifically in neuroprosthetic 
applications, PEDOT/pAAc cryogels were electrically characterized. Current vs. 
voltage curves (IV-curves) for a wide range of gel formulations showed, as expected, 
that conductivity was lower when excited at low voltages (Figure 3.2a, IV-curves had 
relatively small slopes at voltages between -2 and +2 V) and higher conductivities 
when excited at higher voltages (IV-curves had higher slopes at voltages less than and 
greater than -2 and +2 V, respectively). Computed conductivity values for various gel 
formulation and at various voltage excitation values can be found in Figure A6. While 
lower conductivities were recorded at voltage excitation levels lower than the over-
potential at the metal-hydrogel interface, impedance measurements revealed that these 
cryogel systems (for gels cut to 2 x 12-mm cylinders after swelling using an LCR 
meter set to use a 2-volt signal) exhibited impedance magnitudes of < 200 Ohms 
(Figure 3.2b) (for Nyquist plots of these same impedance data, see Figure A7 in 
Appendix A).  Critically, because altering gel formulation can be used to tune gel 
mechanics (Figure 1c, i) without overly impacting gel conductivity (Figure 3.2a and 
3.2b), cryogels could be customized to match the mechanics demanded by the 




In order to determine if these electrical characteristics were sufficient to record 
low-powered neural signals, a specific cryogel formulation that exhibited both 
compressible mechanics (low Young’s modulus and high strain-of-failure) and 
desirable electrical attributes (electrical conductivity nearing 1 S/cm) was selected for 
further study: the 9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogel. This 
cryogel formulation was cast on disc electrodes (Figure 3.2c, i: top), allowed to fully 
swell, and used to record signals emanating from a human subject’s occipital lobe. 
These PEDOT cryogel-integrated disc electrodes (Figure 3.2c, i: bottom (blue)) were 
compared to electrodes integrated with Ten20 conducting paste (Figure 3.2c, i: second 
from top (red)) and a non-cryogelated PEDOT gel (second from bottom (green)). 
Compared to a popular EEG conducting paste (Ten20, which was found to be superior 
to other EEG conducting pastes on the market) [33]. electrodes with PEDOT cryogels 
were able to record neural signals at similar amplitudes and spectral powers (Figure 
3.2c, ii & iii: red and blue curves overlapped). When compared to a non-cryogelated 
PEDOT hydrogel (a formulation comparable to a PEDOT hydrogel reported elsewhere 
[13, 26, 27, 29-32, 34-37]), these cryogels also performed similarly (Figure 3.2c, ii & 
iii: green and blue curves overlapped). Specifically, PEDOT cryogels provided similar 
degrees of signal and spectral resolution to those of a commercially available 
conductive paste and non-cryogel PEDOT gels. This enabled the observation of alpha 
waves when the subjects’ eyes were closed (Figure 3.2c, ii, bottom: peak in signal 
from 7.5 – 12.5 Hz) and decreased alpha waves when subjects opened their eyes 




opened (iii) vs. closed (ii)). Additionally, 1-hour exposure to PEDOT cryogels did not 





Figure 3.2. PEDOT/pAAc cryogels exhibited conductive electrical properties 
sufficient to record neural signals. (a) A schematic (i) and photo (ii) of a 9 wt% 
AAc, 0.26 wt% PEDOT, 1 wt% PEGDM cryogel completing an LED circuit. (b) DC 




wt% (red), 2 wt% (blue), and 5 wt% (blue) PEGDM. (c) (i) Impedance vs. frequency 
for 4 wt% AAc, 0.26 wt% PEDOT cryogels crosslinked with 1 wt% (red) and 5wt% 
(blue) PEGDM. (ii) Impedance vs. frequency for 9 wt% AAc, 0.26 wt% PEDOT 
cryogels crosslinked with 1 wt% (red) and 5wt% (blue) PEGDM. (d) (i) Images of 
disc electrodes with standard Ten20 paste (blue) and a PEDOT cryogel (red). (ii,iii) 
Recorded neural signal vs. time (top) and power spectrum (bottom) when subject’s 
eyes are closed (ii) and open (iii). Insets: power spectrum from 7.5 to 12.5 Hz, 
highlighting alpha wave power. For all parts, n.s. indicates that no statistical 
significance was found (p > 0.05) between any groups (N = 4). 
 
In order to examine how well a fully swollen cryogel retained its mechanical 
and electrical attributes after either treatment with ethanol (often used prior to 
placement on the skin) or autoclaving (for sterilization), 9 wt % AAc, 0.26 wt % 
PEDOT, 1 wt % PEGDM cryogels were mechanically and electrically tested before 
and after ethanol-treatment and autoclaving. It was discovered that 70% ethanol 
treatment did not have a statistical impact on the cryogel’s Young’s modulus (Figure 
3.3a, i: red and blue bars are statistically similar), suggesting that the cryogel’s 
structure was not overtly altered by the treatment. However, autoclaving these 
cryogels was more disruptive and did have an impact on the gel’s mechanical 
attributes (Figure 3.3a, comparing green and red bars/curves). While this may be a 
limitation for using these gels in vivo, note that they could potentially be produced as 
sterilized products in a clean environment with pre-sterilized materials. In terms of 




DC conductivity was not statistically impacted by either ethanol-treatment or 
autoclaving when excited at 0.5 V (Figure 3.3a, ii: no statistically significant 
differences between red, blue, and green bars). This held true when excited at higher 
voltages as well (Figure A9).  
Because these PEDOT cryogels exhibited particularly soft moduli and high 
strains of failure (Figure 3.1c) as well as the electrical ability to transmit neural signals 
(Figure 3.2c), experiments were conducted to examine if these cryogels could survive 
the compressions associated with injection. A cylindrical cryogel was compressed to 
90% of its height and was able to eventually spring back to form after compression, 
remaining structurally intact (Figure 3.3b). This compressibility allowed these 
cryogels to survive being passed through a 16-gauge needle (Figure 3.3c). There have 
been other efforts to create injectable conducting hydrogels, though using in situ 
gelation to achieve injectability [38-40]. While adopting novel in vivo gelation 
strategies, these studies yielded gels that swelled after injection (from 120% to 500%) 
which could be highly problematic since swelling could damage sensitive neural 





Figure 3.3. A PEDOT/pAAc cryogel can retain its mechanical and electrical 
attributes after being treated in ethanol and can survive high degrees of 
compression. (a) Young’s modulus (i) DC conductivity when measured with a 0.5 V 
signal (ii), and impedance vs. frequency (iii) for 9 wt% AAc, 0.26 wt% PEDOT, 1 
wt% PEGDM cryogels before treatment (red) and after ethanol-treatment (blue) or 
autoclaving (red). (b) Stress vs. strain for the same cryogel when brought to and from 
90% compression. Inset: photographs of the cryogel before and after compression. (c) 
Photographs of a 3 x 1.25 mm cylindrical cryogel (as formulated in parts (a) through 





In order to assess the viability of cells in the vicinity of these cryogels, fibroblasts 
studies were performed. 3T3 fibroblasts were plated and allowed to establish 
themselves for 24 hours. A 9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogel 
was then placed directly on top of the 2D culture while fibroblast viability was 
monitored over the subsequent week and compared to controls (Figure 3.4a). 
LIVE/DEAD staining was performed (Figure 3.4b) to quantify cell population and 
viability over time. These analyses revealed that presence of a PEDOT cryogel did 
inhibited fibroblast growth vs time (Figure 3.4c, i: solid curve reaching lower cell 
densities than the dashed curve). This may have been the result of cells physically 
having less space to grow. In fact, the LIVE/DEAD image of the fibroblasts that grew 
for 7 days underneath a PEDOT cryogel reveals spots where cells did not invade 
(Figure 3.4b, bottom right fluorescent image). These could be locations where the 
cryogel made strong contact with the well-plate, physically limiting cell infiltration. 
The presence of a PEDOT cryogel, however, did not statistically impact fibroblast 
viability vs. time (Figure 3.4c, ii). Additionally, cell cycle analyses were performed on 
fibroblasts after exposure to PEDOT cryogels for 10 days (fibroblast doubling time is 
typically 18-24 hours). These studies revealed that PEDOT cryogel exposure did not 
statistically impact the progression of fibroblasts through their cell cycles (Figure 3.4c, 
iii). Propidium iodide (PI) histograms from these cell cycle analyses are provided in 
Supporting Information (Figure A10). The findings here are consistent with other 
reports. Elsewhere, PEDOT-based materials have (i) exhibited good biocompatibility 
with epithelial cells, neural cells, and fibroblasts [41], (ii) incited minimal 




(glial-scar formation around materials implanted in brain tissue) [44].  However, 
further studies are needed to assess PEDOT cryogel biological performance. For 
example, viability, proliferation, and cell cycle analyses for other pertinent cells types 
(e.g., neurons and glia cells) will need to be performed. Additionally, in vivo studies 
will be needed to examine the performance of the specific PEDOT cryogel developed 
here, since the inflammatory response (which is not present in vitro) would play a 
critical role in implant performance.   
Finally, a possible strategy for preserving an electrical pathway at the interface 
between neural tissues and electronic components in vivo is to have that interface 
locally deliver therapeutics that can help prevent fibrotic tissue formation. We 
hypothesized that these hydrogels would be particularly well-suited to locally deliver 
these types of therapeutics. To demonstrate this capability, 9 wt % AAc, 0.26 wt % 
PEDOT, 1 wt % PEGDM cryogels were loaded with Interleukin-4 (IL-4)—a protein 
that can inhibit the inflammatory response of macrophages by differentiating them 
towards pro-repair phenotypes [45-47]. Release studies showed that IL-4 release was 
initially rapid, reaching ~10 ng of cumulative release within the first 24 hours, 
depending on the amount of protein loaded in the gel (Figure 3.4d, blue and red curves 
at 1 day). This initial burst release could be of particular use during the acute phase of 
inflammation immediately following cryogel introduction to the tissue. PEDOT 
cryogels continued to release IL-4 in lesser amounts over the course of the next 30 
days (Figure 3.4d, blue and red curves after day 1). Additionally, these data showed 




the gels with different amounts of protein (Figure 3.4d, comparing the values of blue 




Figure 3.4. PEDOT cryogels do not disrupt fibroblast viability and cell cycle and 
can deliver proteins that may help reduce inflammation. (a) Schematic of in vitro 
viability experiments. (b) Green/red (live/dead) fluorescent images of 3T3 fibroblasts 
on days 1 through 7 when cells are not exposed to a gel (top) or exposed to a 9 wt% 
AAc, 0.26 wt% PEDOT, 1 wt% PEGDM cryogel. (c) Cell density (i) and viability (ii) 
vs. time when cells are not exposed to a gel (dashed curve) or exposed to a the 




cycle after 10 days of exposure to PEDOT cryogels (grey) vs. fibroblasts not exposed 
to gels (white). ** and *** indicate statically differences between cryogel exposed 
cells and controls with p < 0.01 and 0.001, respectively. n.s. indicates that no 
statistical differences were found (p > 0.05). N = 4. (d) Cumulative IL-4 release vs. 
time for the PEDOT cryogel after being loaded with 1 μg (red) or 5 μg (blue) of IL-4. 
N = 4. 
 
Despite not being injectable after fully swelling, the nanoporous PEDOT/pAAc 
room-temperature-cast hydrogels (characterized in Figs. A1-A5) exhibited attributes 
potentially beneficial in many neuroprosthetic applications. Their combination of soft 
but tunable mechanics (Figure A1: 0.5 – 65 kPa), toughness (Figure A3: 30 – 88% 
strain of failures, absorbing 1 – 7.5 kJ/m3 before failing), ability to transmit neural 
signals (Figure 3.2c, green), and ability to remain hydrated (by virtue of being a 
crosslinked network of hydrophilic polymer) could be highly useful in applications 
where electrical contact must be maintained between electrical components and soft, 
curvilinear skin surfaces (e.g., EEG- and ECG-based applications). Use of these 
conductive hydrogels could provide improvements over the conductive pastes 
traditionally used for interfacing between electronics and tissues. For example, 
conductive hydrogels would involve less messy preparation, could conform better to 
irregularly surfaced skin, and could maintain electrical contact for longer periods of 
time without drying out.  
The macroporous PEDOT/pAAc cryogels developed here (Figures 3.1 – 3.4) 




neuroprosthetics applications. These conductive cryogels were composed of relatively 
inexpensive and biocompatible materials and were capable of being formed using 
straightforward techniques. Their tunable and soft (0.2 – 22 kPa Young’s moduli) yet 
tough (1.5 – 6 kJ/m3) and compressible (50 – >90% strain of failures) mechanical 
properties provide specific advantages: (i) better mechanical matches with tissues than 
traditional metal electrodes alone and (ii) enable survivable compression through 
needles after fully swelling, and the ability to inject in or against sensitive tissues 
rather than surgical introduction. These desirable mechanics coincide with electrical 
properties that permit the recording of low-power neural signals, performing as well as 
conductive pastes that are currently commercially available (Figure 3.2c). Moreover, 
when compressed, these PEDOT cryogels’ electrical resistances are significantly 
reduced (Figure A11, nearly 10-fold drop in DC resistance at 80% compressive 
strain), likely due to shortening of the electrical path. Thus, when pressed in or against 
tissues, they are expected to exhibit improved conductivity, enhancing their ability to 
record bio-electrical signals.   
The mechanical and electrical attributes of the PEDOT/pAAc cryogels produced 
here build upon previous successes with formulating electrically conductive 
hydrogels. For example, hydrogels previously formed by interpenetrating electrically 
conductive polymer (such as polyaniline (PANi) or PEDOT) within crosslinked 
polymeric networks resulted in gels with conductivities on the order of 0.001 to 0.034 
S/cm and mechanics appropriate for many applications (fracture strains ranging from 
60% to 90% and compressive stresses up to 1.1 MPa) [13, 15, 25, 35-38, 48]. One 




dual networks (a poly(ethylene glycol) methyl ether methacrylate (PEGMA) network 
and a pAAc network), producing tough (surviving 80% compressive strains under ~4 
MPa stresses with Young’s moduli ~ 90 kPa) and electrically conductive (~1 S/cm) 
gels at close to physiological pHs (pH = 6). Note that these dual network gels’ 
mechanical and electrical properties could be further enhanced by subjecting them to 
acidic environments. While the dual network gels produced by Nacify et al. [13] 
provided excellent mechanical and electrical attributes for use as strain sensors, they 
likely lacked the highly compressible mechanics needed for post-swollen injection 
(i.e., a combination of very low Young’s moduli and high strain of failures). Here, a 
simple cryogelation was used to produce conductive hydrogels with interconnected 
macroporous structures, thus endowing them with softer and compressible mechanics. 
This cryogelation strategy could likely be applied to other conducting hydrogels 
networks (such as those discussed above [13, 25, 35-38, 48] ) as a means to reduce 
stiffness and improve compressibility.    
 
3.4 Conclusion 
In summary, electrically conductive hydrogels with macroporous, soft, and 
compressible attributes were produced using a simple cryogelation approach and were 
shown to be capable of being passed through 16-guage needles for potential injection. 
The mechanical properties of these cryogels were tunable based on formulation, and 
alterations in cryogel formulation did not overly impact electrical performance. 
Cryogel electrical properties were sufficient to record low-power neural signals. These 




7 days but did hinder fibroblast growth and spreading compared to controls. Finally, 
these cryogels were capable of being loaded with anti-inflammatory protein (IL-4), 
releasing this protein over the course of a month.  Taken altogether, these capabilities 
could improve interfaces between tissues and electronics in a wide range of 
neuroprosthetic applications and in other applications that demand soft but tough and 
tunable mechanical properties coupled with the ability to transmit electrical signals. 
 
Supporting Information  
Supporting Information is available at appendix A.   
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Electroencephalography (EEG) is one of the most important noninvasive 
methods for studying the brain’s neural activity, and is used broadly in both diagnosis 
and research. However, conventional EEG methods do not provide adequate spatial 
resolution and signal-to-noise ratios for many emerging diagnostic and research 
applications. To address these inadequacies, high-resolution EEG methods are piquing 
the interest of researchers and clinicians. One such method, the use of tripolar 
concentric ring electrodes (TCREs), utilizes surface Laplacian theory and three 
concentrically arranged electrodes per sensor to address these issues. Although TCREs 
have been shown to significantly improve the spatial resolution and signal-to-noise of 
EEG signals it, like other electrode-to-scalp techniques, requires using conductive 
paste at the electrode-scalp interface. This not only electrically partially short-circuits 
the three concentric channels of the TCRE but also the paste can dry out over time. 
These issues prohibit TCREs from providing their true potential in terms of EEG 
spatial resolution and signal-to-noise ratio, especially in applications that require EEG 
recordings for prolonged periods of time. To address these issues, TCREs with 
electrically conductive hydrogels were developed to (i) eliminate the need for 
conductive paste, (ii) provide improved isolation between channels, and (iii) improve 
signal-to-noise ratio preservation over time. The aim of this work was to develop 
conductive hydrogels, integrate them into TCRE configurations, and characterize their 









Electroencephalography (EEG) is a technique used to measure electrical 
impulses generated by brain activity and is relatively affordable and easy to 
implement. The EEG provides excellent temporal resolution of complex brain signals 
which makes it ideal for diagnosing certain neurological diseases. For example, EEG 
is used to diagnose epilepsy, dementia, Alzheimer’s disease [1], psychosis such as 
depression and schizophrenia [2, 3], and narcolepsy [4]. In addition EEG can be used 
to evaluate the overall brain electrical activity of patients suffering from brain trauma 
[5, 6], extent of brain damage in comatose patients [7], drug intoxication, and 
encephalopathy [8]. Furthermore, EEG is extensively used in rehabilitation 
applications such as in brain-computer interfaces to provide control of prosthetic 
movement in patients with paralysis [9-12]. However, while EEG’s excellent temporal 
resolution makes it highly desirable, EEG does not inherently provide good spatial 
resolution. This limits the use of EEG in emerging research and clinical theaters where 
excellent spatial and temporal resolutions are needed to monitor the spatiotemporally 
complex activities of the brain (e.g., real-time mapping/imaging of brain activity). If 
EEG techniques can be endowed with better spatial resolution, it will prove to be a 





Because of this potential, there are several methods designed to improve the 
spatial resolution of EEG. Some of these methods, based on surface Laplacian theory, 
do not require predetermined modeling of the head’s conductive heterogeneity, but 
nonetheless provide similar results as other methods that do require this predetermined 
modeling (e.g., cortical imaging) [13]. Surface Laplacian methods enhance spatial 
selectivity and source identification, attenuate universal noise, and improve signal-to-
noise ratio. Moreover, surface Laplacian methods are independent of reference 
electrode location and even improve temporal resolutions [11, 14-17]. These attributes 
make these methods superb choices for high resolution EEG. There are many versions 
of surface Laplacian theory to process brain activity and different types of EEG 
electrode designs based on surface Laplacian theories. Most of these electrodes have a 
center conducting disc and one or more ring electrodes around the center disc; for 
example, a bipolar electrode, tripolar concentric ring electrode, and concentric ring 
electrodes (with one center disc and several rings around it). Increasing the number of 
rings around the center disc can enhance spatial selectivity even more, but 
improvements in spatial selectivity become negligible at some point. Studies have 
shown that electrodes with a center disc and two or three rings are the optimal [18, 19] 
(e.g., a center disc with two rings around it: a tripolar concentric ring electrode or 
TCRE, which will be investigated here) (Figure 4.1A). 
Like traditional disc-shaped EEG electrodes, TCRE (and other multi-channel 
electrodes designed based on surface Laplacian theory) require electrical contact with 
the patient’s scalp. To improve the electrical connection between an electrode and the 




improves the electrode-skin interface connection, it also partially electrically shorts 
out the channels of TCRE configuration, somewhat limiting its ability to provide 
enhanced spatial selectivity (Figure 4.1B Right). To make matters worse, conductive 
pastes dry out over time, affecting signal quality and increasing noise over time. This 
limits their use in applications that involve EEG spatiotemporal analysis over 
prolonged periods of time (e.g., in wearable electronics). Thus, technologies that can 
provide prolonged conductive interfaces between TRCEs and a patient's scalp without 
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Figure 4.1. Conductive hydrogel not only provides contact between electrode and 
skin but also improves isolation between channels. Comparison of electrode’s 
contact with skin with different conductive interfaces. (A) Tripolar concentric ring 
electrode (TCRE). (B) Left, TCRE in contact with skin without any interface, Right, 




concentric ring hydrogel electrode (TCRHE) in contact with skin on left and 
schematic of conductive hydrogel on right. 
Hydrogels are soft materials which are made from cross-linked hydrophilic 
polymer networks [21]. Although they are insoluble in water, they can preserve a large 
fraction of water within their network for prolonged periods of time and retain 3D 
shapes, unlike conductive pastes [22]. However, hydrogels typically exhibit poor 
conductivity [23]. Although this is not an issue in many applications, for use as an 
interface between electrodes and skin, conductivity is a critical priority [24, 25]. 
Conductive polymer hydrogels are a unique class of hydrogels which not only have 
soft mechanical properties similar to skin [26], but also have electrical properties like 
metals and inorganic semiconductors [27]. There are several conductive polymers 
available which are widely used for fabricating conductive hydrogels, though for use 
as electrodes in neural interfaces: polypyrrole and poly(3-4, ethylenedioxythiophene) 
(PEDOT) are primarily used [28]. It has recently been demonstrated that PEDOT 
provides improved conductivity and stability in oxidized environments over 
polypyrrole [22, 24, 29-32]. Moreover, PEDOT is biocompatible [33]. Thus, PEDOT 
will be employed as the conductive component of the hydrogel electrodes.  
While PEDOT hydrogels have been created previously, they have yet to be 
employed as a means to enhance spatial resolution of multi-electrode systems by 
providing soft, 3D conducting structures that retain their shape and moisture over 
prolonged periods of time. Thus, the work proposed here is a novel step forward in the 
context of contemporary technologies. The hypothesis guiding this work is that 




desirable shape (i.e., a TCRE configuration) and retain that shape, thus providing 
improved isolation between TCRE channels and prolonged conductivity and contact 
with scalp (Figure 4.1C). Specifically, this study involves the synthesis of conductive 
hydrogels with multiple polymers and crosslinkers and evaluation of their structural, 
mechanical and electrical behaviors to identify an optimal hydrogel formulation to 
integrate into TCRE configuration and refine electrode design to optimize its 
performance and improve channel isolation. Moreover, we performed EEG testing to 
compare hydrogel-integrated TCRE (TCRHE) to regular TCRE with conductive paste. 
 
4.2. Materials and Methods 
 
4.2.1 Materials 
For alginate-PEDOT (alg-PEDOT) hydrogels, alginate (PROTANAL 
LFR5/60) was purchased from FMC. Adipic acid dihydrazide (AAD), 1-
hydroxybenzotriazole hydrate (HOBt), N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC), poly(3,4-ethylenedioxythiophene)-
poly(styrene sulfonate) (PEDOT:PSS) and phosphate buffered saline (PBS) were 
purchased from Sigma-Aldrich (St. Louis, MS). Sigmacote for coating glass sheets 
was purchased from Sigma-Aldrich (St. Louis, MS). All materials were used without 
any modification.  
For polyacrylic acid-PEDOT (PAAc-PEDOT) hydrogels, acrylic acid (AAc), 
sodium hydroxide (NaOH), poly(ethylene glycol) dimethacrylate (PEGDM), poly(3,4-




on), N,N,N',N'-Tetramethylethylenediamine (TEMED), ammonium persulfate (APS), 
aluminum oxide column, and phosphate buffered saline (PBS) were purchased from 
Sigma Aldrich. All materials were used without any modification, except AAc, which 
was purified using aluminum oxide column to remove the inhibitor. 
To fabricate the tripolar concentric ring hydrogel electrode (TCRHE), a 
tripolar concentric ring electrodes (TCREs) were acquired from CREmedical. The 
tripolar concentric ring mold (TCR mold) was printed using a 3D printer. Epoxy 
(marine epoxy) and sealant were purchased from Amazon and the conductive hydrogel 
was fabricated in a manner described in detail in the next sections. 
 
4.2.2 Hydrogel synthesis 
For preparation of alg-PEDOT hydrogels, alg-AAD solution was prepared 
first, where different amounts of alginate (2 – 5 wt %) were added to deionized water 
(DI water) and stirred until fully dissolved. The AAD (2.5 and 5 mM) and HOBt were 
added to the mixture until fully dissolved, and the resulting solutions were stored at 
4C. 2 ml of alg-AAD solution was mixed with 2.5 ml of PEDOT, 0.5 ml of EDC (50 
mg/ml) was added, and immediately after mixing the mixture was poured onto a 
Sigmacoted glass sheet. Another piece of Sigmacoted glass sheet was placed on top of 
the solution with 2 mm spacing, and after 30 minutes hydrogels were cut with a biopsy 
punch and stored in PBS. 
To make pAAc-PEDOT hydrogels, different amounts of purified AAc (4 -10 
wt %), PEGDM solution (1, 2 and 5 wt %), NaOH solution (465 µl per ml of AAc), 




or may not be added) were added and vortexed. TEMED and APS (137 mg/ml) were 
then added to the solution to initiate gelation. This solution was immediately 
transferred to 10x10 mm cylindrical Teflon molds and left to gel at room temperature 
for three hours. Samples were then removed and stored in PBS. 
 
4.2.3 Degree of swelling 
To measure degree of swelling, the height and diameters of the hydrogels were 
measure before immersion into PBS to evaluate their volume (Vbefore). After samples 
were fully swollen and had reached equilibrium their height and diameters were 
measured again (Vafter), and degree of swelling was calculated from: 
 
degree of swelling =    Eq. 4.1 
 
4.2.4 Mechanical characterization 
The Young’s modulus, strain of failure (SoF) and toughness of the hydrogels 
were quantitively measured using a compression testing. For mechanical 
characterization, the sample was placed between grids of an Instron Universal Testing 
System (Model 3345) and compressed until failure. After the compression test on a 
given sample, a stress-strain curve was obtained, and mechanical properties such as 
Young’s modulus, strain of failure and toughness were obtained from this curve. 
 




Prior to measuring the electrical properties of the hydrogels, fully swollen 
samples were cut into discs 12  0.1 mm in diameter and 2  0.1 mm in height. A 
sample was then placed between electrodes and -8, -2, -1.5, 1.5, 2 and 8 Volts (Electro 
industries DIGI 360) were applied, and the current (Fluke 115) was measured. For 
measuring impedance (LCR-6300), hydrogels were exposed to different frequencies 
(10, 50, 60, 100, 120, 1000, 2000, 10000, 20000, 40000, 50000 and 100000 Hz at 10 
mv) and the magnitude of impedance and phase angle were recorded.   
 
4.2.6 Hydrogel electrode fabrication 
Molds with ring sizes and heights similar to those of the TCRE were printed 
using a 3D printer (Original Prusa i3 MK2). Figure 4.2A show the TCRE, and Figure 
4.2B illustrates the mold design. Sealant was applied on the edge of the electrode wall 
between the rings (Figures 4.2C (i) and 4.2D (i)) to improve insulation between the 
rings. A traditional TCRE (prepared ahead of time) was inserted inside the mold and 
the electrode back was covered with epoxy. Hydrogels were prepared as described 
previously, and were injected into the mold, where Figures 4.2C (iv) and 4.2D (iv) 
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Figure 4.2. Fabrication of tripolar concentric ring hydrogel electrode (TCRHE). 
(A) Tripolar concentric ring electrode (TCRE). (B) TCR mold holds both the TCRE 
and conductive hydrogel. (i) TCR mold oblique view. (ii) TCR mold side view, (iii) 
TCR mold top view. (C) Schematic of fabricating TCRHE step-by-step. (i) Applying 
sealant on the edge of wall between rings to isolate channels and inserting TCRE. (ii) 
TCRE is inserted into mold and mold is ready for injection of hydrogel. (iii) Hydrogel 
is being injected with 22 gauge needle. (iv) TCRHE. (D)  Fabrication of TCRHE step 
by step. (i) Sealant is applied on the edge of walls between rings to isolate channels 
and inserting TCRE. (ii) TCR mold is ready for injection of hydrogel. (iii) hydrogel is 
being injected with 22 gauge needle into TCR mold. (iv) TCRHE. Hydrogel mixture 





4.2.7 Insulation between rings 
To measure the insulation between the channels, impedance between the 
channels was measured using an LCR meter. Wires attached to each ring were 
connected to the impedance meter, and impedance was measured at 10, 50, 60, 100, 
120 and 1000 Hz with a 10 mv excitation voltage in ideal conditions, where TCRHE 
and TCRE with Ten20 paste were exposed to air.  
 
4.2.8 Electroencephalography (EEG) testing 
EEG test was performed on four volunteers, two male and two females. All 
volunteers signed IRB consent form. A typical EEG test setup was used. Briefly, 
ground and reference electrodes (gold disc electrodes with Ten20 paste) were put on 
the forehead of a patient, and TCRHEs and TCRE were placed on the occipital lobe 
using a headband. A TCRE with Ten20 paste (as the conductive interface) was in the 
center (Oz) and TCRHEs were on the left (O1) and right (O2) occipital lobes. The 
electrode attachment sites were swiped with Nuprep prior to testing. The volunteer 
was asked to alternately open and close their eyes for about 60 seconds periods. The 
tEEG and TCRHE signals were pre-amplified (187.5 V/V) with a t-Interface 20 2.0 
(CREmedical Corp.), then amplified (1000 V/V) and digitized (200 S/s) with a Grass 
Comet Plus (Grass technologies West Warwick RI) by notch filtering with range of 1-
70 Hz while recording. I assume you used a tInterface. 
 




A volunteer was asked to wear electrodes for 4h and EEG testing was 
performed using the method previously described. The volunteer moved around freely 
while wearing the electrodes.  
 
4.2.11 Signal-to-noise ratio  
The noise was estimated by obtaining the power spectrum between blinks (1 s) 
and the signal-to-noise ratio was derived by dividing the power spectrum for the 
condition with eyes closed by the noise.  
 
4.2.12 Statistical analysis 
All experiments were performed at least four times. The results were reported 
as mean  standard deviation. MATLAB was used to evaluate FFT on EEG results to 
acquire the power spectra and signal-to-noise ratios. Statistical analysis was performed 
using ANOVA (analysis of variance) with Tukey’s HSD (honestly significant 
difference) test at a significance level of 0.05. * indicates p-values < 0.05, ** indicates 
p-values < 0.01, *** indicates p-values < 0.001 and **** indicates p-values < 0.0001. 
 
4.3. Results and discussion 
 
4.3.1 Hydrogel synthesis and degree of swelling 
To successfully fabricate a tripolar concentric ring hydrogel electrode, a 
conductive hydrogel formulation that can remain intact inside the mold should first be 




with different polymer and cross-linker concentrations were fabricated. The 
conductive polymer (PEDOT) concentration remained constant (0.26 wt %) for all 
hydrogel formulations. 0.26 wt % PEDOT was the maximum concentration needed 
since initial experiments showed that using higher concentrations of PEDOT did not 
improve gel conductivity (data not shown). As shown in Figure 4.3, hydrogel volumes 
were measures before and after being fully swollen in PBS to measure and compare 
the degree of swelling, which was between 3 – 12 for PAAc-PEDOT hydrogels 
(Figure 3A(iii)). PAAc-PEDOT hydrogels were injected into a TCR configuration, 
and as expected, they swelled significantly and did not remain inside the mold. Figures 
4.3A (i) and 4.3A (ii) show two different PAAc formulations with the lowest and 
highest degrees of swelling, respectively.  
On the other hand, the degree of swelling remained around 1 for the alg-
PEDOT formulations (Figure 4.3B (ii)), indicating that the degree of swelling for alg-
PEDOT hydrogels was independent of their formulation parameters. Alg-PEDOT 
hydrogel formulations were also injected into a TCR mold, and remained in the mold, 
proving that alg-PEDOT hydrogels had a degree of swelling around 1 (Figure 4.3B 
(i)). The significant differences in the swelling behavior of PAAc-PEDOT and alg-
PEDOT hydrogels are due to the differences in the polymer chains of alginate and 
polyacrylic acid. In the hydrogel formulations, sodium ions are present to make cross-
linking possible. When the hydrogel swells in PBS, there is a pH difference between 
hydrogel network and surrounding medium, and water moves into the hydrogel matrix 
until it reaches equilibrium. There are more sodium ions within the PAAc hydrogel 




more than alginate hydrogels. Figure 4.3 A(iii) demonstrates that by increasing the 
amount of polymer present in the formulation that the degree of swelling increases, 
since with increasing polymer concentration, sodium ion concentration increases for 
both alginate and PAAc. However, there is a higher concentration of sodium oxide 
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Figure 4.3. Alg-PEDOT hydrogel exhibit comparably little swelling. Comparison 
of the degree of swelling for different conductive hydrogels with different polymers 
including (A) P(AAc) and (B) alginate as the backbone. (A) Integration of P(AAc)-
PEDOT hydrogel into TCR format for (i) hydrogel with 4 wt % P(AAc), 5 wt % 
PEGDM and 0.26 wt % PEDOT (lowest degree of swelling). (ii) Hydrogel with 9 wt 
% P(AAc),1 wt % PEGDM and 0.26 wt % PEDOT. (iii) Comparison of degree 
swelling for a wide range of P(AAc) (4 - 10 wt %) and PEGDM (1, 2 and 5 wt%) with 
constant 0.26 wt % PEDOT. (B) Hydrogel made from different concentration of 
alginate and AAD have a swelling degree around 1. (i) Alginate-PEDOT hydrogel 




PEDOT. (ii) Comparison of degree of swelling for a wide range of alginate (2 - 5 wt 
%) and AAD (2.5 & 5 mM) with constant 0.26 wt % PEDOT. N = 4 for all parts. 
 
4.3.2 Mechanical properties 
For diagnostic purposes, patients frequently are asked to wear electrodes for up 
to 24 hours [34]. To make testing more bearable for patients, especially children, we 
aimed to use conductive hydrogels that have similar mechanical properties to skin, and 
at the same time ones that exhibit favorable toughness to ensure long-term integrity of 
the electrodes. To do so, the mechanical properties of the hydrogels, namely Young’s 
modulus, strain of failure and toughness were measured (Figure 4.4). Figure 4.4A 
shows the mechanical properties of alg-PEDOT hydrogel formulations. The Young’s 
modulus was between 2 – 16 kPa for these formulations, and these data indicated that 
with increasing polymer and crosslinking concentrations, the Young’s modulus 
increases. The alg-PEDOT formulations had Young’s modulus values similar to skin 
(Young’s modulus between 50 – 150 kPa [35]). Furthermore, these hydrogel 
formulations demonstrated toughness between 2 – 25 kJ/m3 (Figure 4.4B), where the 
toughness increased with increasing alginate and cross-linker concentrations. The 
hydrogel formulations can withstand high strains (75 % - 83 %) (Figure 4.4C) and alg-
PEDOT hydrogels with 2 wt % alginate/2.5 mM AAD/0.26 wt % PEDOT had a 
significantly higher strain of failure in comparison to other formulations. Toughness 
and strain of failure are important properties to ensure the long-term robustness, and 




There have been reports of fabricating conductive hydrogels with PEDOT [36] 
and  3-4, ethylenedioxythiophene (EDOT) monomer (monomer form of PEDOT) [22]. 
In these studies, other synthesis methods were used to fabricate a double network 
conductive hydrogel which resulted in high Young's modulus and toughness. 
Critically, in our study, we demonstrated the ability to explicitly tune hydrogel 
mechanical properties by varying the polymer and cross-linker concentrations. 
Moreover, the method of conductive hydrogel synthesis described here enables a 
relatively fast and straightforward gel fabrication method, and can be adapted for a 


































































































Figure 4.4. Hydrogel mechanics are tunable while degree of swelling remains 
around 1. Different hydrogel formulations made from alginate (2- 5 wt%) and 
crosslinked with AAD (2.5 & 5 mM) with constant 0.26 wt% PEDOT. Mechanical 
characteristics of hydrogels including (A) Young's modulus, (B) toughness, and (C) 
strain of failure. N = 4 for all studies. 
 
4.3.3 Electrical properties 
Hydrogel electrical properties are independent of their formulation as shown in 




different alginate and crosslinker concentrations at different voltages. At each 
measured voltage, there were no statistically significant difference in the current read 
from hydrogel formulation. Also, the impedance of the hydrogels was measured at 
different frequencies at 10 mv, and the impedance of the hydrogels decreased with 
increasing frequency for all gel formulations. These data confirmed that there was no 
statistically significant difference in impedance of the hydrogel formulations at each 
frequency (Figure 4.5B). Moreover, the conductivity of these hydrogels was evaluated 
at 1.5 v, 2 v and 8v to have a better understanding of their behavior at given voltages 
(Figure 4.5C), where the conductivity of hydrogels increased with increasing voltage. 
The highest conductivity (about 1 S/cm) was achieved at 8 v.  
The conductivity of the hydrogels at any given voltage is controlled by 
overpotential. The independence of electrical properties from the formulations was 
expected since the same amount of PEDOT (0.26 wt %) was used for all formulations. 
Furthermore, our early tests showed that the electrical properties of the hydrogels did 
not change with changing PEDOT formulation (data not shown). Independence of 
electrical behavior from the formulation is beneficial as it allows for the hydrogel 
properties to be tuned depending on the application requirements. A variety of 
conductive hydrogel formulations with different amounts of polymer and conductive 
polymer components have been designed, resulting in systems with different 
properties. For example, depending on the synthesis method and PEDOT/EDOT 
concentrations, conductivities between 6.8 x 10-4 to 1 S/cm have been reported for 
conductive hydrogels [22, 33, 37-40]. Zhao et al. [36] reported conductivities greater 




(PPy) conductive polymers. The electrical conductivities reported here and in the 
described studies [22, 33, 37-40] are likely appropriate for electrical stimulation and 
sensing of neural tissue. For instance, the conductivities of scalp, skull and brain tissue 
are 0.33 x 10-3, 0.0042 x 10-3 and 0.33 x 10-3 S/cm, respectively [41, 42]. Overall, 
electrode materials should exhibit high conductivities for proper sensing and 
stimulation, and the hydrogels designed in this study provide electrical conductivities 
well above the described tissues. Furthermore, since the hydrogel formulations 
exhibited similar electrical properties, alg-PEDOT hydrogels with 2 wt % alginate, 2.5 
mM AAD and 0.26 wt % PEDOT were chosen for fabricating TCRHE since they had 
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Figure 4.5. Hydrogel electrical properties are independent of hydrogel 
formulation. (A). IV curve for different hydrogel formulations made from alginate (2- 
5 wt%) and crosslinked with AAD (2.5 & 5 mM) with constant 0.26 wt% PEDOT. 8, 
4, 2, 1.5, -1.5, -2, -4 and 8 v voltages were applied, and currents were read. (B). 
Impedance for different hydrogel formulations made from alginate (2- 5 wt%) and 




applied from 10 to 105 Hz at 10 mv voltage. (C) Conductivities for different hydrogel 
formulations made from alginate (2-5 wt %) and crosslinked with AAD (2.5 & 5 wt 
%) with constant 0.26 wt % PEDOT at (i) V = 1.5 v, (ii) V = 2 v, and (iv) V = 8 v. For 
all studies N = 4 and n.s. indicates that no statistically significant difference was found 
(p > 0.05). 
 
4.3.4 Isolation between TRE rings 
One of the main issues with TCREs is the use of conductive paste, which is 
applied between the scalp and electrodes that partially shorts the electrode channels 
and affects the quality of signals. Additionally, conductive paste dries over time which 
affects the long-term stability of the system. To ensure isolation between the channels 
present in the TCRHE, impedance between the channels was measured. Furthermore, 
TCRHE with two heights (2.5 and 5 mm) were fabricated to optimize the design of the 
system (Figures 4.6 B1). Impedance between two channels was measured at a time. 
Figures 4.6A, 4.6B and 4.6C demonstrated impedance between the middle ring to 
center disc, center disc to outer ring and middle ring to outer ring for TCRHE, 
indicating that the impedance between the channels were at least two orders of 
magnitude higher for these systems than TCRE with conductive paste. Higher 
impedance between channels is an indication of isolation between the rings (Figures 
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Figure 4.6. TCRHE exhibit much better isolation between channels in 
comparison to conductive paste, where high impedance between channels 
indicates isolation. (A) Isolation between middle ring to center disc. Red for TCRE 
with Ten20 paste and blue for 2.5 mm TCR hydrogel electrode (2.5 mm TCRHE) (2 
wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT). (B) Isolation between center 
disc to outer ring. Red for TCRE with Ten20 paste and blue for 2.5 mm TCR hydrogel 
electrode (2.5 mm TCRHE) (2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT). 
(C) Isolation between outer ring to middle ring. Red for TCRE with Ten20 paste and 
blue for 2.5 mm TCR hydrogel electrode (2.5 mm TCRHE)) (2 wt % alginate, 2.5 mM 
AAD and 0.26 wt % PEDOT). Frequency was applied from 10 to 1000 Hz at 10 mv 
voltage. 
 
4.3.5 EEG testing 
Volunteers (two male and two female) were involved in the study and signed 




comparison, to TCREs, EEG testing was performed while volunteers wore the 
aforementioned electrodes. Figures 4.8 and B3 demonstrated that TCRHE exhibited 
better performance compared to TCRE with Ten20 paste, providing higher potential 
and power spectrum, especially while patient eyes were closed. Figures 4.7A and S3A 
show real-time recording and alpha rhythms, where the alpha rhythm is normal brain 
activity when conscious and relaxed, consisting of oscillations of 8 – 13 Hz. Such 
rhythms can be detected from the occipital lobe while eyes are closed, and was clearly 
observed for all of the electrodes evaluated (2.5 and 5 mm TCRHE and TCRE with 
Ten20 paste). Results showed that 2.5 mm TCRHE exhibited higher amplitude in 
comparison to TCRE with Ten20 paste. Figures 4.7B and B2B show the power spectra 
of the electrodes while patients' eyes were closed, and the inset data showing the 
power spectrum for alpha waves clearly indicate that 2.5 mm TCRHE exhibited better 
performance in comparison to TCRE with Ten20 paste. Figures 4.7C and B3C show 
real-time EEG recordings, where alpha rhythms disappeared as soon as the eyes were 
opened. Figures 4.7D and B2D show the power spectra of TCRE and TCRHE while 
the volunteer's eyes were open. The data showed that TCRHE can not only record 
neural activity, but also have better performance than TCRE with Ten20 paste. 
Moreover, Figure B2 shows that 2.5 mm TCRHE exhibited better performance 
than 5 mm TCRHE. Since impedance decreases with decreasing thickness, 2.5 mm 
TCRHE outperformed 5 mm TCRHE as it had lower impedance. In addition, the 2.5 
mm TCHRE had a higher signal-to-noise ratio than the 5 mm TCRHE and TCRE with 
Ten20 paste at its peak. The increase in performance of the 2.5 mm TCRHE in 




was also shown that by decreasing the electrode lead height, the signal-to-noise ratio 
could be further enhanced (Table 4.1). Since the 2.5 mm TCRHE exhibited better 
performance parameters and had higher signal-to-noise ratio than the 5 mm TCRHE 






































































































































Figure 4.7. TCRHE have higher amplitude and significantly improves the power 
spectrum in comparison to TCRE with Ten20 paste. (A) EEG recording from 
occipital lobe using Ten20 paste (red) compared to hydrogel (2.5 mm lead electrode 
(blue)) while subject eyes were closed. Inset: zoom-in EEG recording while eyes were 




hydrogel (2.5 mm electrode lead (blue)) while subject eyes were closed. Inset: zoom-
in power spectra, highlighting the recording of alpha waves (8-13 Hz) only with eyes 
closed. (C) EEG recording from occipital lobe using Ten20 paste (red) compared to 
hydrogel (2.5 mm lead electrode (blue)) while subject eyes were opened. Alpha wave 
vanished as soon as eyes were opened. (D) Power spectrum from occipital lobe using 
Ten20 paste (red) compared to hydrogel (2.5 mm lead electrode (blue)) while the 
subject’s eyes were open. Alpha waves disappeared as soon as eyes were opened. For 
all parts, N = 4 at 0 hour. * indicates p-values < 0.05. 
 
4.3.6 EEG longevity test  
To characterize the durability of the electrodes, EEG testing was performed 
after the subject wore electrodes for 4 hours continuously, while moving around 
freely. As seen in Figure 4.8, alpha waves were detected and the TCRHE had a higher 
signal amplitude compared to TCRE with Ten20 paste. Figure 4.8B shows the, 
displayed  power spectra while the subject’s eyes were closed, and the inset illustrates 
the alpha wave power spectra, indicating that TCRHE had higher power than TCRE 
with Ten20 paste after 4h. Figure 4.8D (power spectrum) show data where the 
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Figure 4.8. TCRHE have higher amplitude and significantly improve the power 
spectrum comparing to TCRE with Ten20 paste. (A) EEG recording from occipital 
lobe using Ten20 paste (red) compared to hydrogel 2.5 mm lead electrode (blue) while 
subject eyes were closed. Inset: zoom-in EEG recording while eyes were closed. (B) 
Power spectrum from occipital lobe using Ten20 paste (red) compared to hydrogel 2.5 
mm electrode lead (blue) while subject eyes were closed. Inset: zoom-in power 
spectra, highlighting the recording of alpha waves (8-13 Hz) only with eyes closed. 
(C) EEG recording from occipital lobe using Ten20 paste (red) compared to hydrogel 




disappeared as soon as eyes opened. (D) Power spectrum from occipital lobe using 
Ten20 paste (red) compared to hydrogel 2.5 mm lead electrode (blue) while subject 
eyes were open. Alfa waves disappeared as soon as eyes opened. For all parts, N = 4 at 
4 hours. * indicates p-values < 0.05, ** indicates p-values < 0.01. 
 
Table 4.1. Signal-to-noise ratio of electrodes at 0h and 4h for alpha wave (8 – 13 
Hz). Signal-to-noise ratio for alpha oscillation for TCRE with Ten20 paste and 2.5 




Ten20 paste 2.5 mm TCRHE 5 mm TCRHE 
 0h 4h 0h 4h 0h 4h 
8 0.66  0.11 1.26  0.85 0.87  0.17 1.81  0.79 1.03  0.28 - 
9 0.96  0.37 1.15  0.54 1.25  0.2 1.46  0.55 1.07  0.27 - 
10 3.22  4.01 2.53  0.54 5.61  1.23 2.72  0.98 2.10  0.51 - 
11 19.38  2.38 11.65  3.57 21.16  1.77 11.44  2.35 11.69  2.95 - 
12 21.46  2.38 14.48  2.68 22.96  8.13 11.15  1.46 14.27  5.62 - 
13 6.20  1.65 5.06  0.66 5.61  1.90 4.61  1.04 4.64  3.21 - 
 
 
Figure 4.9 shows the performance of TCRHE and TCRE with Ten20 paste 
over time at 8 - 13 Hz while eyes were closed (alpha waves). The conductive hydrogel 
and electrode design enhanced signal amplitude and maintained a steady interface 




TCRHE power after 4 hours, whereas the power decreased over time for TCRE with 




























































Figure 4.9. TCRHE had higher power spectrum compared to TCRE with Ten20 
paste over time. 8 - 13 Hz (alpha waves) while subject’s eyes were closed. N = 4 for 
all parts. * indicates p-values < 0.05, ** indicates p-values < 0.01, *** indicates p-
values < 0.001 and **** indicates p-values < 0.0001. 
 
The aim of this work was to develop a novel conductive polymer hydrogel 
serving as an interface between an electrode and skin tissue combining the beneficial 
properties of hydrogels with excellent electrical properties of PEDOT. With such 
interfaces, it is important to consider a design which provides a stable, durable 
interface with the tissue. To achieve this goal, we developed a fabrication method of 
conductive hydrogels where the conductive hydrogel was made using commercially 




with tunable mechanics and favorable electrical properties for the described 
application. This method of fabrication can be adapted for a wide range of negatively 
and neutrally charged polymers.  
There has been significant effort to develop electrodes that eliminate the use of 
a conductive interface (dry electrodes). Some of the most attractive features of dry 
electrodes are their robustness and ability to adapt to body curvature. On the other 
hand, dry electrodes have high impedance and do not provide a good connection 
between the electrode and skin, resulting in poor signal quality. These features limit 
the use of dry electrodes and thus conductive paste is used to overcome such 
limitations (wet electrodes). Conductive paste dries over time, which can affect the 
quality of recorded signals [43, 44]. Recent advances in the integration of materials 
and electronic systems have resulted in a new generation of dry electrodes which 
integrate conductive hydrogels [45-47] and conductive polymers [48] within the 
electrodes. PEDOT:PSS was used as conductive interface to fabricate hydrogel-based 
dry electrodes. These designs, different in their natures (electrode type and conductive 
layer), improved the quality and stability of EEG signals, and enhanced the impedance 
and signal-to-noise ratio of electrodes. Our conductive hydrogels are robust, similar to 
dry electrodes, and provide a good connection with skin tissue as wet electrodes do. 
 
4.4. Conclusion 
In conclusion, we developed a new design to integrate a conductive interface 
within an electrode that maintained a good connection with skin for successful EEG 




thickness that resulted in stronger signal amplitudes than that of regular TCREs with 
conductive paste. Additionally, the hydrogel-based electrodes maintained their 
integrity over time. Moreover, by decreasing the electrode design’s signal-to-noise 
ratio will be improved. Overall, this work shows a new fabrication approach that can 
be used to integrate a conductive hydrogel interface with electrodes, creating new 




Supporting information can be found in Appendix B. 
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CONCLUSIONS AND FUTURE WORK 
 
5.1 Conclusions 
This dissertation focused on the fabrication, development, optimization and 
characterization of conductive hydrogels. Several conductive hydrogels systems were 
made using commercially available conductive polymer. The method of hydrogel 
production was fast and does not require specific instruments. Additionally, both 
natural and synthetic polymers were used to fabricate conductive hydrogels with this 
method, demonstrating the versatility in the method itself. 
In the third chapter, we used the synthetic polymer polyacrylic acid to make 
hydrogels at room and sub-freezing temperatures in order to fabricate conductive 
hydrogels with different morphologies (macroporous and nanoporous structures). The 
macroporous cryogel exhibited shape memory properties, making them suitable for 
injection. Furthermore, by changing the formulation of the cryogels wide range 
mechanical properties; young’s modulus between 0.2 – 20 kPa, high strain of failure 
(they could endure 90 % compressive strain) and excellent toughness (above 2 kJ/m3), 
were achieved. These properties are crucial to ensure the robustness and durability of 
these materials. Additionally, the hydrogels exhibited sufficient conductivity to record 
neural activity. Finally, the materials were biocompatible, and were loaded with and 




In chapter 4, we used the natural polymer alginate to make conductive 
hydrogels to be incorporated into electrodes. In this work, the goal was to integrate 
conductive hydrogels into a tripolar concentric electrode configuration to enhance 
channel isolation, and to fabricate electrodes that can record neural activity for 
prolonged periods of time. To do so, we used nanoporous hydrogels that could hold a 
large amount of water within their network. The resulting alginate-PEDOT (alg-
PEDOT) hydrogels exhibited a high strain of failure (above 80 %) and great toughness 
(above 2 kJ/m3). Integration of the alg-PEDOT hydrogel into a tripolar concentric ring 
configuration significantly enhanced channel isolation (about two order of magnitude). 
In addition, the optimized electrode design amplified neural activity recorded with the 
hydrogel-based electrodes in comparison with tripolar concentric ring electrode 
(TCREs). The optimized design enhanced the signal-to-noise ratio of the electrode, 
and this electrode design overcomes the limitation of using conductive paste. In 
addition, the given system was found to be robust and can adapt to body curvature, 
allowing the system to be more advantageous to previously-described designs.  
 
5.2 Future work 
This dissertation demonstrated a fast and easily accessible method for the 
fabrication of conductive hydrogels. Many opportunities exist to conduct further 
research with these materials, which may include, but is not limited to: 
• Investigation of localized protein and drug delivery using cryogels by 




this system, which would also involve investigating the appropriate electric 
and polarity properties for safe drug delivery.  
• Optimizing the mold design for TCREs by fabricating electrodes and molds as 
one piece. In this manner, the electrode lead height could be reduced and the 
signal-to-noise ratio could be further enhanced. 
• With the capabilities of the enhanced special resolution of TCREs and 
conductive hydrogels capabilities to be fabricated in any design, targeted drug 
delivery and multi-drug delivery using tripolar concentric ring hydrogel 







Supplementary Materials for Chapter 3 
 




PEDOT-integrated cryogels exhibit porous, soft and highly compressible 
mechanics and can electrically transmit neural signals.  PEDOT cryogels exhibit 
macroporous structures that enhance softness and compressibility which enables 
injection through a 16-guage needle. Cryogel conductivity is sufficient to record EEG 






Figure A1. Nanoporous PEDOT/pAAc hydrogels exhibit soft and tunable 
mechanics. (a) Compressive modulus vs. acrylic acid concentration for gels 
crosslinked with 1 wt% (red), 2 wt% (blue), and 5 wt% (green) PEGDM. “No 
gelation” indicates that there was not enough polymer and crosslinker to form a 3D gel 
structure and therefore no measurement could be taken. (b) Table summarizing 
statistically significant differences of moduli between different hydrogel formulations. 








Figure A2. The electrical properties of hydrogels are not significantly impacted 
by acrylic acid and PEGDM crosslinking concentration. (a) I-V curves for gels 
composed 0.26 wt% PEDOT and (i) 4 and 7 wt% AAc, (ii) 9 wt% AAc, and (iii) 10 
wt% AAc. (b) Computed DC electrical conductivity for various 0.26 wt% PEDOT 
hydrogel formulations when excited using (i) 0.5 V, (ii) 2 V, (iii) 4 V, and (iv) 8 V. 
n.s. indicates no statistically significant differences. N = 4. Note that some gel 







Figure A3. Many hydrogel formulations exhibit high strains of failure and 
toughness. Strain of failure (a) and toughness (b) vs. acrylic acid concentration for 
gels crosslinked with 1 wt% (red), 2 wt% (blue), and 5 wt% (green) PEGDM. “No 
gelation” indicates that there was not enough polymer and crosslinker to form a 3D gel 
structure and therefore no measurement could be taken. For all parts, N = 4. In part (a) 
the dashed line at 90% indicates that compression tests never exceeded 90% as to not 
risk damaging the equipment, though no gels reached 90% compression due to failure 









Figure A4.  Nanoporous PEDOT/pAAc gel formulations swelled well beyond 
their original volumes after casting. Ratio of swollen volume over ordinally cast 
volume for PEDOT/pAAc gels vs. acrylic acid concentration for gels crosslinked with 
1 wt% (red), 2 wt% (blue), and 5 wt% (green) PEGDM. “No gelation” indicates that 
there was not enough polymer and crosslinker to form a 3D gel structure and therefore 









Figure A5. Nanoporous PEDOT/pAAc gel cannot survive the strains associated 
with injection. (a) Compressive stress vs. strain of for a 5 x 5 cm cylindrical 9 wt% 
AAc, 0.26 wt% PEDOT, 1 wt% PEGDM hydrogel, until failure (b) Photographs of a 3 
x 1.25 mm cylindrical hydrogel (formulated as in part (a)) before and after injection 


















Figure A6.  PEDOT cryogels exhibited similar DC conductivities over a wide 
range of gel formulations. DC conductivity vs. gel formulation for cryogels 
containing 0.26 wt% PEDOT when excited at 0.5 V (a), 2 V (b), 4 V (c), and 8 V (d). 







Figure A7. Nyquist plots for a range of PEDOT cryogel formulations exhibit 
similar characteristics. (a) Real vs. imaginary component of impedance for 4 wt% 
AAc PEDOT cryogels crosslinked with 1 wt% (red) and 5 wt% (blue) PEGDM. (b) 
Real vs. imaginary component of impedance for 9 wt% AAc PEDOT cryogels 












Figure A8. Exposure to PEDOT cryogels did not visually impact the skin. Subject 
forearm before gel placement (top), after 1 hour of exposure when gels (middle), and 
immediately after gel removal (bottom). PAAc-PEDOT cryogel was made at 9 wt% 
AAc, 1 wt% PEGDM, and 0.26 wt% PEDOT. The PAAc cryogel was made at 9 wt% 

















Figure A9. Ethanol-treatment and autoclaving PEDOT cryogels do not 
statistically alter electrical conductivity. DC electrical conductivity computed at 2 V 
(a), 4 V (b), and 8 V (c) for PEDOT cryogels (9 wt% AAc, 1 wt% PEGDM, and 0.26 
wt% PEDOT) before treatment (red), after ethanol-treatment (blue), or after 
autoclaving (green). n.s. indicates that no statistically significant differences were 




















Figure A10. PEDOT cryogel-exposed fibroblasts do not exhibit different cell 
cycles as compared to controls. Histograms of propidium iodide (PI) intensity for 
fibroblasts after 10 days when not exposed to PEDOT cryogels (top row) compared to 
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Figure A11. PEDOT/pAAc cryogel DC resistance decreases as the gel is 
compressed. DC resistance vs. compressive strain for 9 wt% AAc, 0.26 wt% PEDOT, 
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Figure B1. TCR hydrogel electrode have a much better isolation between 
channels. High impedance between channels indicates isolation.  (A) isolation 
between middle ring to center disc. Red for TCRE with Ten20 paste, blue for 2.5 mm 
TCR hydrogel electrode (2.5 mm TCRHE) and green 5 mm TCR hydrogel electrode 
(5 mm TCRHE) (2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT).  (B) 
isolation between center disc to outer ring. Red for TCRE with Ten20 paste, blue for 
2.5 mm TCR hydrogel electrode (2.5 mm TCRHE) and green 5 mm TCR hydrogel 
electrode (5 mm TCRHE) (2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT). 
(C) isolation between outer ring to middle ring. Red for TCRE with Ten20 paste, blue 




electrode (5 mm TCRHE) (2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT). N 









































































































































Eyes open  
 
Figure B2. TCR hydrogel electrode have higher amplitude and significantly 
improves power spectrum comparing to TCRE with Ten20 paste. (A) EEG 
recording from occipital lobe using TEN20 paste (red) compared to hydrogel (2.5 mm 
lead electrode (blue) and 5 mm lead electrode) while subject eyes were closed. (i) 
Inset: zoom-in EEG recording while eyes were closed. (B) Power spectrum from 
occipital lobe using TEN20 paste (red) compared to hydrogel (2.5 mm electrode lead 
(blue) and 5 mm lead electrode (green)) while subject eyes were closed. (i) Inset: 
zoom-in power spectra, highlighting the recording of alpha waves (8-13 Hz) while 
eyes were closed. (C) EEG recording from occipital lobe using TEN20 paste (red) 




subject eyes were opened. Alfa wave was gone as soon as eyes were opened. (D) 
Power spectrum from occipital lobe using TEN20 paste (red) compared to hydrogel 
(2.5 mm lead electrode (blue) and 5 mm lead electrode(green)) while subject eyes 
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